Computational discovery and analysis of metabolic pathways by Heath, Allison Park
RICE UNIVERSITY 
Computational Discovery and Analysis of 
Metabolic Pathways 
by 
Allison Park Heath 
A THESIS SUBMITTED 
IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE 
Doctor of Philosophy 
APPROVED, THESIS COMMITTEE: 
UAJJAACL ¥\cwrait/ 
Lydia E. Kavraki (Chair 
Professor of Computer Science 
Rice University 
George N. Bennett 
Professor of Biochemistry and Cell Biology 
Rice University 
Luay K. Nakhleh 
Assistant Professor of Computer Science 
Rice University 
"Jl/\r— 
Gafbor Balazsi 
Assistant Professor of Systems Biology 
The University of Texas MD Anderson 
Cancer Center 
Houston, Texas 
June, 2010 
UMI Number: 3425217 
All rights reserved 
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted. 
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed, 
a note will indicate the deletion. 
UMT 
Dissertation Publishing 
UMI 3425217 
Copyright 2010 by ProQuest LLC. 
All rights reserved. This edition of the work is protected against 
unauthorized copying under Title 17, United States Code. 
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
Abstract 
Finding novel or non-standard metabolic pathways, possibly spanning multiple species, has 
important applications in fields such as metabolic engineering, metabolic network analysis, 
and metabolic network reconstruction. Traditionally, this has been a manual process, but the 
large volume of metabolic data now available has created a need for computational tools to 
automatically identify biologically relevant pathways. This thesis presents new algorithms 
for automatically finding biologically meaningful linear and branched metabolic pathways 
in multi-genome scale metabolic networks. These algorithms utilize atom mapping data, 
which provides the correspondence between atoms in the substrates to atoms in the products 
of a chemical reaction, to find pathways which conserve a given number of atoms between 
desired start and target compounds. 
The first algorithm presented identifies atom conserving linear pathways by explicitly 
tracking atoms during an exploration of a graph structure constructed from the atom mapping 
data. The explicit tracking of atoms enables finding branched pathways because it provides 
automatic identification of the reactions and compounds through which atoms are lost or 
gained. The thesis then describes two algorithmic approaches for identifying branched 
metabolic pathways based upon atom conserving linear pathways. One approach takes one 
linear pathway at a time and attempts to add branches that connect loss and gain compounds. 
The other approach takes a group of linear pathways and attempts to merge pathways that 
move mutually exclusive sets of atoms from the start to the target compounds. 
Comparisons to known metabolic pathways demonstrate that atom tracking causes the 
algorithms to avoid many unrealistic connections, often found in previous approaches, and 
return biologically meaningful pathways. While the theoretical complexity of finding even 
linear atom conserving pathways is high, by choosing the appropriate representations and 
heuristics, and perhaps due to the structure of the underlying data, the algorithms in this 
thesis have practical running times on real data. The results also demonstrate the potential 
of the algorithms to find novel or non-standard pathways that may span multiple organisms. 
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Chapter 1 
Introduction 
Metabolism refers to the chemical reactions, typically catalyzed by enzymes, that occur to 
sustain life. Experimental studies, coupled with advancements in molecular biology and 
improved computational methods, have generated increasingly large amounts of data on 
metabolic reactions and pathways in the last few decades. As a result, many specialized 
databases have been created in order to store and organize this metabolic data [56, 21]. One 
of the major goals of these databases is to make the data easily navigable and interpretable 
by their users. The data is usually presented as many small subpathways that are manually di-
vided based on function and sometimes by organism. However, it can be difficult to navigate 
these subpathways to find connections between compounds, especially for discovering novel 
or non-standard pathways that may span multiple organisms. These type of pathways can be 
important for a number of applications such as metabolic engineering [9], understanding 
the metabolic scope of multi-species communities [36, 119] and metabolic network recon-
struction [92, 35]. Combining parts of pathways existing in different organisms can lead 
to new ways of considering how metabolism works in complex communities and provide 
novel ways to synthesize important and useful compounds. 
Computational tools can provide a way to automatically find biologically interesting 
pathways in metabolic data and reveal pathways that may have not been identified by manual 
means. The primary problem that computational methods for metabolic pathfinding try 
to solve is given a start and target compound, find "biologically meaningful" or "realistic" 
pathways of enzymatic reactions that make the target compound from the start compound. In 
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many ways, methods for metabolic pathfinding can be thought of as "search engines" which 
try to find metabolic pathways, similar to finding websites, of interest from a large amount 
of data. In both cases, it is not always clear what the best results are, pathways or websites, 
to return for a particular query. Instead, it is dependent on the specific application that the 
user has in mind. While "biologically meaningful" and "realistic" are not well-defined, it 
is important to provide an initial validation of metabolic path finding tools based on their 
ability to find known metabolic pathways or by manual analysis of the results. 
Graphs provide well-suited computational framework for modeling metabolism as a 
network, where the compounds and reactions are the vertices of the graph and the edges 
connect the compounds to the reactions they are involved in. Additionally, finding paths 
in graphs is a well-studied problem with a number of efficient algorithmic solutions for 
finding shortest and k shortest pathways. Unfortunately, as further discussed in the next 
chapter, paths found in standard graph representations of metabolic networks often do 
not correspond to biologically meaningful pathways [6, 35]. The work in this thesis is 
based on the observation that these graph-based methods do not work because they remove 
information about what is really going in a reaction biochemically. Each edge connecting 
the compounds to the reaction are considered the same, but biochemically one compound 
may be just providing the energy to drive the transformation of another chemical. One must 
look at the atomic level to understand which substrate chemicals are being transformed into 
which product chemical. 
In the last few years the availability of atomic level information on which atoms in 
the substrate compounds correspond to which atoms in the product compounds, called 
atom mapping data, has been steadily increasing. The algorithms presented in this thesis 
harness atom mapping data to track atoms through metabolic networks to find pathways 
which conserve atoms from a given start compound to a give target compound. Atom 
3 
tracking greatly increases the complexity of finding pathways in metabolic networks as 
compared to standard ways of finding paths in graphs. The general problem of finding linear 
pathways that conserve a given number of atoms, using atom mapping data, from the start 
to the target compound has been proven to be PSPACE-complete, and NP-complete when 
pathways are constrained to only use a compound once [17]. Fortunately, experimental 
results demonstrate that linear atom conserving pathways can be found in efficiently in 
practice. This is likely due to the underlying structure of metabolic networks combined with 
the fact that the number of atoms being tracked is often low. Atom tracking is a crucial 
feature, when using graph-based methods, for finding meaningful metabolic pathways 
because it essentially eliminates spurious connections and reactions that do not correspond 
to useful or real biochemical pathways or reactions. Furthermore, atom tracking enables 
finding branched metabolic pathways. 
Branched metabolic pathways refer to pathways that contain linear pathways that interact 
biochemically to produce one molecule of the target compound. For example, a target 
compound may be made of three molecules of glucose, a six carbon compound, that undergo 
different modifications before participating in reactions to combine the molecules into one 
larger final compound. In this case, the number of atoms conserved is the total number of 
atoms that go from the starting molecules of glucose to the target compound. If all carbon 
atoms are conserved from the molecules of glucose, the branched pathway would be said 
to conserve 12 carbon atoms. Finding branched pathways that conserve a give number of 
atoms while using less than a given number of reactions has been shown to be NP-hard 
by reduction from the minimum set cover problem [91]. However, unlike the linear atom 
conserving pathways, finding branched pathways in practice appears to be closer to the 
theoretical complexity of the general problem. Therefore, algorithmic solutions require the 
use of heuristics in order to obtain branched, atom conserving, metabolic pathways. 
4 
1.1 Contributions 
The main contribution of this thesis are three novel algorithms for finding both linear and 
branched metabolic pathways by using atom mapping data to track the movement of atoms 
through metabolic networks. The goal of these algorithms is to find biologically meaningful, 
possibly novel, metabolic pathways that may utilize reactions from multiple organisms 
without focusing on a particular organism or prior information on the environments in which 
they function. The algorithms all take as input atom mapping data, a start compound, a 
target compound, a minimum number of atoms to conserve and a maximum number of 
pathways to return. A set of metabolic pathways, that conserve at least given number of 
atoms from the start compound to the target compound, are returned. The first algorithm, 
LPAT, guarantees finding the k shortest linear metabolic pathways that conserve a given 
number of number of atoms. Even though this problem is of high theoretical complexity, 
experimental results show that the computational time required for LPAT is on the order 
of minutes in practice. The other algorithms, BPAT-S and BPAT-M, tackle the problem 
of finding branched metabolic pathways. Development of these algorithms revealed that 
finding branched metabolic pathways is a more complex problem in practice than finding 
linear metabolic pathways, even though they are of similarly high theoretical complexity. 
Therefore, BPAT-S and BPAT-M take two different heuristic approaches for finding branched 
metabolic pathways. This thesis also contributes extensive experimental testing of the 
algorithms, using metabolic data spanning multiple organisms, to demonstrate their practical 
performance. The results of the heuristic approaches of BPAT-S and BPAT-M are compared 
and highlight the different advantages and disadvantages of the approaches. The analysis 
of experimental results demonstrate that the algorithms in this thesis can find biologically 
meaningful and interesting pathways and improve on the current state of the art algorithms 
for find metabolic pathways. 
5 
1.2 Thesis Outline 
The rest of the thesis proceeds by first providing background information and an overview 
of related work in Chapter 2. Chapter 3 describes LPAT, the algorithm developed for finding 
linear metabolic pathways using atom tracking. The computational complexity of finding 
branched metabolic pathways requires the use of heuristics, and so Chapter 4 presents 
two different algorithms, BPAT-S and BPAT-M, utilizing different heuristic approaches, 
for accomplishing this task. Chapter 5 describes the experimental setup and testing of all 
of the algorithms presented. The experimental setup describes how metabolic data was 
obtained and processed and the hardware used, and the experimental testing revolves around 
understanding how well the algorithms find known metabolic pathways. Chapter 6 is the 
final chapter, containing the conclusions and future directions for this work. 
6 
Chapter 2 
Background 
The study of metabolism, the chemical reactions that occur in cells to maintain life, has a 
long and rich history now spanning hundreds of years. The textbook version of metabolism 
breaks it down into relatively small and easy to understand metabolic pathways, such as 
glycolysis and the citric acid cycle [69]. While there is no denying that understanding the 
central metabolic pathways is important, in the last few decades, advances in molecular 
biology have greatly increased our knowledge and revealed a more complex picture of 
metabolism. The current view of metabolism is a network, rather than a set of straightfor-
ward pathways, containing all of the biochemical reactions which occur within an organism. 
A visualization of the metabolic network of E. coli can be found in Figure 2.1. This network 
view demonstrates the complexity found in just the metabolic network of one organism. 
A closer look reveals that a number of alternative pathways can exist to perform the same 
metabolic function or multiple pathways typically thought of as separate may be intercon-
nected by using the same chemical compounds or enzymes. Finding interconnections and 
alternative pathways is important for understanding metabolism overall as well as how to 
make useful modifications to metabolic networks. 
Modern molecular biology has not only enabled better understanding of metabolic 
networks, but has also brought the ability to manipulate metabolic networks through ge-
netic engineering techniques. This has created a whole area of research, termed metabolic 
engineering, that is focused on the rational design, or redesign, of the genetic and regula-
tory processes in an organism, in order to increase production of a desired substance [9]. 
7 
Figure 2.1 : Visualization of the metabolic network of Escherichia coli obtained from 
KEGG. The magenta nodes represent enzymatic reactions and the green nodes are chemical 
compounds. The network contains 2570 nodes and 5238 edges. The figure was made using 
Cytoscape [109]. 
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Metabolic engineering has resulted in the successful biosynthesis of a number of compounds 
such as amino acids [71], drugs and drug precursors [68], and biofuels [67]. Metabolic engi-
neering is a complex task which often requires extensive experimental trial and error. The 
metabolic engineering process begins by selecting a desired chemical product. Metabolic 
engineers then must carefully search multiple databases and scientific literature for metabolic 
reactions involving the desired product and possible precursors. These reactions usually 
come from more than one organism. This is a lengthy process with a goal of discovering a 
set of efficient reactions. To test this candidate network, specific genes are inserted into a 
host organism, incorporating the relevant reactions. Therefore, there is need for creating 
computational tools to help assist and accelerate the metabolic engineering process. 
Computational techniques are well suited for automatically finding pathways in multi-
genome scale metabolic networks that could be potentially used for metabolic engineering. 
Automated identification of metabolic pathways also has applications in areas such as 
metagenomics and metabolomics to assist with metabolic network reconstruction and 
understanding the metabolic scope of communities of organisms composed of multiple 
species [36, 119]. The algorithms in this thesis are general enough that they can be used for 
finding metabolic pathways for other applications, but the experimental results are geared 
towards metabolic engineering applications. 
There have been two major areas of previous work on computationally finding metabolic 
pathways that differ primarily on the type of model used: stoichiometric, also known as 
constraint-based, and graph-based, also known as pathfinding, approaches [92, 65]. Both 
approaches have advantages and disadvantages and therefore, as highlighted by a recent 
pair of papers, the choice of approach is related to the specific biological questions that 
one wants to answer [34, 27]. Stoichiometric approaches require that the stoichiometry of 
metabolic reactions be satisfied and require the specification of the compounds that exist in 
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the system. Stoichiometric approaches are better utilized for the analysis of small metabolic 
networks, frequently from a single organism, to understand the properties and behavior 
of the network. Graph-based methods model metabolic networks as graphs and typically 
ignore stoichiometric constraints. This enables graph based approaches to analyze much 
larger metabolic networks and find pathways without knowledge of the compounds that 
exist in the system. However, ignoring stoichiometric constraints also means that graph 
based approaches can return spurious connections and pathways. Therefore, a number of 
heuristics have been introduced in order to overcome this problem. The work in this thesis 
solves the problem of spurious connections by explicitly tracking atoms from the input 
compounds to the output compounds of a reaction. 
The rest of this chapter will first provide an overview of the current state of available 
metabolic data, which is required for any metabolic path finding method. This will be 
followed by a brief discussion of stoichiometric methods, as they were the first computational 
methods for finding metabolic pathways, but not closely related to the work in this thesis. 
The chapter will conclude with a discussion of graph based approaches, which are more 
directly related to the work in this thesis, for finding both linear and branched metabolic 
pathways. 
2.1 Metabolic Data Sources 
A number of databases have been created in recent years to store and organize the ever 
increasing amount of data on metabolism. In April 2010, Pathguide, a listing of biological 
pathway resources, contained 58 currently available biological pathway resources related to 
metabolic data. These resources vary in their focus, size, curation levels, availability and 
popularity [8]. The current trend reveals that both the quality and quantity of metabolic 
data is increasing and becoming more difficult to search through and analysis manually. 
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Therefore, methods which can automatically identify relevant pieces of data are also be-
coming increasingly important. The goal of metabolic path finding applications is to find 
relevant pathways by using data about enzymatic reactions and the input and output chemical 
compounds. There are two major types of online databases that contain this type of the data. 
The first are metabolic pathway databases, which organize the reactions into pathways and 
focuses on the relationship of these pathways. The second are enzyme databases that focus 
on individual enzymes and their properties. 
Two of the largest online databases focusing on metabolic pathway data are the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) PATHWAY [56] database and MetaCyc 
[21], part of the larger BioCyc Database Collection [58]. MetaCyc and KEGG both contain 
similar data about metabolic pathways and their components and are freely available for 
academic use, but they vary in how this data is organized, curated and made available. 
The KEGG PATHWAY database was initially released in December 1995 and contained 
a selected number of metabolic pathways. KEGG PATHWAY is manually curated and 
drawn based on the literature. The database in April 2010 contained 159 reference pathways 
under the metabolism category. Each reference pathway represents a metabolic function 
(e.g., glycolysis) and contains the enzymatic reactions and chemical compounds which 
make up the pathway. The reference pathways contain the union of the reactions and 
compounds found across organisms, one can then select a particular organism of interest 
and the reactions and compounds found in that organism will be highlighted on the pathway. 
Each of the reactions and compounds found in KEGG are given a unique identifier, either 
starting with "R" for reaction or "C" for compound followed by five digits. KEGG is 
continually expanding, in April 2010, KEGG contained 107,071 pathways generated from 
356 reference pathways, including pathways not related to metabolism, and information on 
129 eukaryotes, 1005 bacteria and 79 archaea. 
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KEGG also hosts databases which provide further information about the enzymes 
and compounds, along with cross linking to other databases via GenomeNet [55]. All 
of the data found in KEGG is free for academic users and can be downloaded via FTP 
in different flat file formats or accessed through web services. The reference metabolic 
pathways are also provided in KEGG Markup Language (KGML), an XML-based format 
created by KEGG. More recently, KEGG PATHWAY has been expanding to include other 
biological pathways such as those involved in genetic information processing, environmental 
information processing, cellular processes, human diseases and drug development. However, 
the metabolic pathway maps still remain the most popular feature [56]. 
MetaCyc is also an independent metabolic pathway database which contains manually 
curated information from scientific literature. MetaCyc was first released in 1999, in 
conjunction with EcoCyc, a database containing pathway and genome information about 
Escherichia coli. In April 2010, MetaCyc consisted of more than 1,470 metabolic pathways, 
across more than 1,800 organisms. It also contains information about the compounds and 
enzymes in these pathways and takes great care to provide the primary literature sources that 
the data was obtained from. The MetaCyc data is freely available to all users in different file 
formats, including BioPAX and SBML. There is also a BioCyc software package, free for 
academic usage, called Pathway Tools which provides analysis and visualization capabilities. 
MetaCyc and KEGG are highly similar resources in that their overall goal is to store 
and organize metabolic pathway data. However, there are some important philosophical 
differences in how they accomplish this task. The main being that the MetaCyc pathways 
attempt to capture a metabolic pathway that functions in an individual organism while 
the KEGG pathways are the union of pathways that can be found in multiple organisms. 
This means that the KEGG pathways are typically larger than the corresponding MetaCyc 
pathways. This is highlighted by comparing the lysine biosynthesis pathways as represented 
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Figure 2.2 : KEGG's reference pathway for lysine biosynthesis. The small circles represent 
individual chemical compounds and the rectangles represent enzymes and are labeled with 
EC numbers. The solid directed edges connect the substrate and products to their enzymatic 
reactions. The rounded ovals are other metabolic pathways and the dotted edges connect 
chemical compounds to other metabolic pathways. 
by KEGG in Figure 2.2 and MetaCyc in Figure 2.3. MetaCyc also provides the user with 
several different layers of detail to view each pathway, as shown in Figure 2.3 while there 
is only one level of detail provided for the KEGG pathways. On both the KEGG and 
MetaCyc websites each individual element is clickable and takes the user to a page with 
more information about that element. 
Additionally, from the beginning MetaCyc has put heavy emphasis on providing the 
primary literature sources coupled with descriptions of each pathway that often discuss the 
variants of the pathway in different organisms. In contrast, KEGG has only recently begun 
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Figure 2.3 : Three MetaCyc pathways for lysine biosynthesis. The pathway on the left is 
lysine biosynthesis I and the one in the top right is lysine biosynthesis IV. Both of these 
pathways contain just one pathway found in the corresponding KEGG pathway in Figure 
2.2. MetaCyc also offers several levels of detail to display, the pathway in the top right 
and bottom right are both lysine biosynthesis IV displayed with two different levels of 
detail. The chemical compounds are connected by directed edges which are labeled with the 
enzyme's name and EC number which catalyzes the reactions. 
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to provide literature sources and typically provides fewer for a given pathway than MetaCyc. 
KEGG has begun to include one paragraph pathway descriptions for their pathways, but this 
is currently only available for a few of the central pathways such as glycolysis and citrate 
cycle and just gives a brief overview of the chemical reactions. 
The differences between KEGG and MetaCyc means that determining which one is 
better depends on the specific application in mind. MetaCyc takes a more organism specific 
role while KEGG takes a broader view of metabolism. Both resources are valuable for 
researchers interested in metabolism and in the ideal case the data from both sources could 
be integrated together. Due to the independent nature of the databases, data integration is 
non-trivial, but MetaCyc has made an effort to cross link to KEGG in order to make data 
integration easier. In version 13.6 of MetaCyc 4292 out of 8334 compounds and 3267 out of 
8540 reactions had corresponding KEGG IDs. While this is a good start, integrating the data 
from the two sources is still no easy task and becomes even more difficult when considering 
different data sources such as enzyme databases. 
Enzyme databases, such as such as BRENDA (BRaunschweig ENzyme DAtabase) [22] 
and ExPASy-ENZYME [11], are also an important source of metabolic data that can be 
used for metabolic path finding. These databases differ from metabolic pathway databases 
such as KEGG and MetaCyc as they focus on data on specific enzymes and do not organize 
the reactions in pathways. Enzyme databases provide more detailed information about each 
reaction, such as functional and kinetic parameters, that may be important in understanding 
the feasibility and dynamics of a metabolic pathway. 
BRENDA was originally created in 1987 and has seen steady growth and improvements 
since its beginning. BRENDA is manually curated and currently contains data for over 5,000 
enzymes acquired from more than 79,000 primary literature references [22]. BRENDA 
is also supplemented by data from FRENDA and AMENDA which contain data from 
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automated text-mining of the literature. The first release of ExPASy-ENZYME was in 
1993 and it has also been greatly expanded and regularly updated through the years. It is 
primarily concerned with storing information on the nomenclature of enzymes and so it does 
not contain as much information as BRENDA does about the properties of each enzyme. 
However, it does provide cross links to a number of other databases and is part of the broader 
ExPASy (EXpert Protein Analysis SYstem) server [40] and could play an important role in 
data integration. 
One of the major issues with integrating the enzyme data with metabolic pathway data 
is that since the enzyme databases are not as concerned with the relationships between 
the reactions, the chemical compounds are not given unique identifiers. Rather, they use 
human-friendly names for the substrates and products of the enzyme and even within the 
database these names may not be consistent. This makes it a challenge to map these names 
to specific compounds found in databases like KEGG and MetaCyc. 
The focus of this thesis is the development of algorithms for metabolic path finding, not 
data integration, and therefore in the current work all of the data used comes from KEGG. 
Additionally, as described in Section 2.1.1, KEGG is the only database that contains corre-
sponding atom mapping data which is required for the algorithms in this work. Integrating 
other data sources is an important direction for future work and is further discussed in the 
conclusions chapter. 
2.1.1 Atom Mapping Data 
Even as metabolic databases have greatly increased the number of reactions and compounds 
they contain, they have traditionally lagged behind in providing atom mapping data. Atom 
mapping data provides a mapping between each atom in the substrate compounds of a 
reaction to the corresponding atom in the product compounds of the reactions. An illustration 
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Figure 2.4 : Atom mapping data obtained from KEGG for the reaction catalyzed by alanine 
transaminase (KEGG ID: R00258, EC Number: 2.6.1.2). Underneath each compound is 
its common name and its KEGG ID. The colors together with the atom labels indicate 
which atoms in the substrates map to which atoms in the products. For example, the 
carbons in alanine, CI, C2 and C3, become CI, C2 and C3 in pyruvate and the carbons 
in 2-oxoglutarate, CO, CI, C2, C3, C5 and C7, become CO, CI, C2, C3, C5 and C7 in 
L-glutamate. No hydrogens are illustrated as they are not included in the atom mapping 
data. 
of the reaction catalyzed by alanine transaminase (KEGG ID: R00258, EC Number: 2.6.1.2) 
using atom mapping data from KEGG can be found in Figure 2.4. The atomic level detail 
of reactions provided by atom mapping data enables explicit tracking of atoms through 
metabolic networks. The ability to track atoms through metabolic networks has a number of 
applications in understanding and manipulating metabolism, such as metabolic path finding 
and radioisotope-tracer experiments [48, 16, 6, 5]. The algorithms presented in this thesis 
are based upon atom mapping data, which has recently become increasingly available. 
The large scale availability of atom mapping data is a result of coupling computational 
methods with manual curation. The problem of finding atom mappings can be formalized 
by representing the chemical structure of the compounds as a graph and attempt to find a 
set of cuts that produce isomorphic components between the substrate and product com-
pounds of the reactions. In the general case, finding a set of cuts of size C is NP-hard 
[1]. However, since chemical compounds are graphs of bounded degree, if the number of 
substrate compounds, p, product compounds, q, and C is held constant then the problem 
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becomes 0((nc)^+^) [1]. While this does cover a number of reactions, it is difficult to 
tell without manual intervention if this is the case for a particular reaction. Therefore, a 
common approach is to use heuristic or approximate algorithms to iteratively find maximum 
common substructures (MCS), an NP-hard problem [39], between the substrate and product 
compounds and then manually fix errors. This approach typically requires an extensive 
amount of manual curation and was used to build the ARM database which contains data 
for carbon, phosphorus and nitrogen atoms for about 3000 reactions [7]. A similar approach 
was taken to build the KEGG RPAIR database, arguably the largest source of atom mapping 
data currently available [57, 62]. 
The experiments in this thesis use data acquired from the KEGG RPAIR database [57,62]. 
The KEGG RPAIR database was built by using a combination of manual curation and the 
computational method SIMCOMP [45, 46]. SIMCOMP differs from the computational 
methods used to create the ARM database in that it does not take into account a whole 
reaction, but rather only finds the MCS between two compounds. The RPAIR entries are 
created by manually examining reactions in KEGG and splitting them into substrate-product 
compounds pairs. These pairs are then used as input to SIMCOMP and the output of 
SIMCOMP is then checked manually and corrected if there are errors. The corrected atom 
mapping of the compound pairs become the RPAIR entries and are assigned a unique 
identifier starting with "RP" followed by five digits. 
Since the RPAIR entries only contain atom mapping between a pair of compounds, the 
atom mapping for most reactions is determined using several RPAIR entries. For example, 
the atom mapping for the reaction in Figure 2.4 is determined by using four different RPAIR 
entries corresponding to the four different colors. Table 2.1 contains the atom mapping 
data obtained from the four different RPAIRs combined together to determine the overall 
atom mapping data for the entire reaction. In turn, each RPAIR entry may be associated 
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with multiple reactions. For example, in the RPAIR entries downloaded from KEGG in 
February 2010, the RPAIR entry between 2-oxoglutarate and L-Glutamate (RP000014) was 
associated with 69 reactions. In the same data, there were 12,079 RPAIR entries involved 
in 7525 reactions out of a total 8098 reactions stored in KEGG. While the KEGG RPAIR 
database has a high level of coverage of the reactions in KEGG, there has been interest in 
developing better computational tools for automatically identifying atom mapping in order 
to reduce the high level of manual curation currently required. 
Computationally solving the atom mapping problem has two major issues, one being 
the complexity, as discussed previously in this section [1]. The other is that the formal 
definition of the atom mapping problem involves finding a set of cuts of size C, but it 
does not provide an optimization criteria. Typically, this is to minimize C, but this is a 
heuristic that does not always correspond to the actual chemistry. Additionally, for the 
minimal C there frequently several solutions and there needs to be criteria to choose between 
them. One solution, proposed by Blum and Kohlbacher, is to cluster reactions by their EC 
number and identify the frequency of different chemical transformations in each cluster [16]. 
When multiple atom mappings exist for the minimal C the one that corresponds to the most 
common chemical transformation in the reaction's EC cluster is chosen. 
Other approaches strive to minimize the number of bonds broken and formed in the 
reaction. Crabtree and Mehta provided five algorithms to find atom mappings based upon 
this criteria, one which is exhaustive and the other four based upon different heuristics 
[25]. They demonstrated that the best performing of their heuristic algorithms, evaluated 
on several benchmarks, finds the optimal solution 84-91% of the time. A similar approach 
by Heinonen et al. uses an A* based algorithm that finds the atom mapping that minimizes 
the number of broken and formed bonds [48]. Additionally, their algorithm can incorporate 
weights on the bonds, which can be used to represent chemical criteria such as the energy 
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Table 2.1 : The four RPAIR entries needed to obtain the atom mapping for the reaction in 
Figure 2.4. The chemical drawing depicts the two compounds in the RPAIR; the atoms 
mapped in each RPAIR entry are colored and labeled the same as in Figure 2.4; the other 
atoms are b 
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required to break or form a particular bond. This recent work on computational methods 
for improving the automated determination of atom mappings bodes well for the increasing 
availability of atom mapping data. 
2.2 Stoichiometric Approaches for Metabolic Pathfinding 
The first approaches for computationally finding metabolic pathways were based upon 
stoichiometric models of metabolic networks [92]. These approaches typically focus on one 
organism or system, and require the user to define which compounds are present or available 
to the cell. Stoichiometric models utilize the steady-state assumption and therefore require 
explicit labeling of internal and external compounds. The internal compounds are balanced, 
that is their creation and consumption are equivalent while the external compounds are free 
to be created or consumed as required. This can be a disadvantage as there are feasible 
biochemical pathways that do not obey the steady-state assumption and/or a compound that 
labeled as internal could easily be provided as an external compound [92]. The algorithms 
found in this thesis strive to find interesting metabolic pathways that may span multiple 
organisms without information such as what organisms or what compounds exist in the 
environment. These algorithms should be perceived as complementary to stoichiometric 
methods; in the future the paths found by the path finding algorithms may be incorporated 
with stoichiometric models in order to further understand how new paths may behave when 
introduced into an organism. However, stoichiometric approaches are widely used and it is 
relevant to understand the differences between stoichiometric and graph based approaches 
for metabolic pathfinding. 
In 1986, Seressiotis and Bailey published the first method, Metabolic Pathway Synthesis 
(MPS) for finding pathways that convert one chemical compound into another in metabolic 
networks [107, 108]. They also introduced the concept of genetically independent pathways. 
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A pathway is genetically independent if no subset of the pathway's reactions is also a 
pathway from the same source and target compound. MPS takes in a source compound, a 
target compound and a metabolic network and then performs an exhaustive search to find all 
stoichiometric balanced, genetically independent pathways. MPS was tested on a network 
containing about 90 reactions and 120 compounds. In the early 1990s, Mavrovouniotis et al. 
presented a branch and bound algorithm for finding genetically independent pathways that 
satisfy stoichiometric constraints [77, 76]. This algorithm allowed for specifying multiple 
compounds as sources and targets and operates by iteratively satisfying constraints. It was 
tested on a network containing about 250 reactions and 400 compounds. 
MPS and Mavrovouniotis' algorithm are both exhaustive algorithms that are exponential 
in the worst case. They were tested on networks that are relatively small compared to 
metabolic networks of interest today that contain thousands to tens of thousands of reactions 
and compounds. While the criteria of genetic independence and the structure of metabolic 
networks helps limit the scope of the search, the exhaustive search of both algorithms 
becomes too computationally expensive to apply to these larger networks. Additionally, it 
may be of interest to identify non-genetically independent pathways because the additional 
reactions may have other implications such as energy production or regulation. 
Stoichiometric models subsequently became a popular way to computationally study 
metabolic networks. Flux balance analysis (FBA) emerged as a powerful, experimentally 
validated, and widely used way to analyze the fluxes through metabolic networks [121, 32, 
96, 86]. It differs from path finding approaches in that it's primary goal is to provide a global 
view of the fluxes through a metabolic network. FBA sets up the stoichiometric constraints 
as a set of linear equations and then creates a heuristic optimization function based upon 
the idea that the cell is trying to optimize its growth. Solving this linear programming 
problem results in a set of fluxes for each reaction which can then be analyzed to find high 
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flux pathways or compared to the fluxes that result after a reaction is added or removed. 
Elementary flux modes (EFMs) are a related approach that is directed more towards finding 
"fundamental" or "ideal" pathways in metabolic networks [104, 102, 103]. An EFM is a 
minimal, or non-decomposable, set of reactions that operates at steady state, while also 
respecting any irreversible reactions. The set of EFMs is unique and finite for a metabolic 
network, however the number of EFMs increases combinatorially in relation to the size of 
the network [60]. Therefore, while there is evidence that EFMs can be useful for identifying 
metabolic pathways, it is currently limited to analysis of relatively small networks. 
Other stoichiometric models have been geared more towards identifying new pathways 
for metabolic engineering applications. One such example is OptStrain, whose goal is to 
identify the minimum number of reactions to add to a host organism to produce a desired 
compound while also maximizing the theoretical yield of the compound [90]. This is done 
by first creating a "super" metabolic network, which in the study contained about 4800 
compounds and 5700 reactions. This network is then used to calculate the theoretical 
maximum yield of the desired product. The reactions are labeled as native or non-native 
based upon whether they occur in the host organism and the problem is formulated as a mixed 
integer linear program where the number of non-native reactions are minimized while still 
maintaining the theoretical maximum yield. Several computational results were presented 
on hydrogen production in three different microbes as well as the production of vanillin 
from glucose in E. coli, OptStrain is the most closely related of the pure stoichiometric 
models to the algorithms found in this thesis, as its goal is to find new metabolic pathways 
that can be utilized for metabolic engineering purposes. However, it still is hobbled by the 
disadvantages that face all stoichiometric models in that it does not allow for unbalanced 
pathways. 
Petri nets lie on the boundary of stoichiometric and graph-based path finding methods 
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because of their flexibility in specifying firing rules [23, 61, 133, 63]. Petri nets are an 
attractive modeling tool for metabolic networks because of their rich theoretical foundations 
[82] and the straightforward analogy of compounds as tokens and reactions as transitions. 
The firing rules of petri nets are typically based upon stoichiometric constraints that are 
highly similar to stoichiometric models, and a number of concepts in petri net analysis 
correspond to independently developed stoichiometric analysis methods. For example, the 
T-invariant of such a petri net is the same as the previously discussed elementary modes 
[105]. However, unlike stoichiometric models, petri net firing rules can be relaxed so 
that they do not follow the stoichiometric constraints, thus making them more similar to 
graph-based approaches. Work by Kuffner et al. demonstrates how the pathways found in 
petri nets vary depending on the constraints used [63]. They constructed a large petri net 
containing data from KEGG, MetaCyc and BRENDA. Results were reported for pathways 
from glucose to pyruvate that were constrained to having a maximum length of nine. They 
found over 500,000 unrestricted pathways in the network, when stoichiometric constraints 
were applied this was reduced to about 80,000. They also investigated restricting the cut 
width of the pathways to 2 and 1, which resulted in 541 and 170 pathways respectively. 
Their results demonstrated the large number of alternative pathways in multi-genome scale 
metabolic networks. 
Stoichiometric models are adept at analyzing the metabolic networks under steady 
state conditions and this analysis can be used to identify pathways in metabolic networks. 
However, graph-based approaches arguably provide a more natural framework for directly 
identifying pathways in metabolic networks, especially in large networks and in non-steady 
state conditions. 
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2.3 Graph-Based Approaches for Metabolic Pathfinding 
Graphs provide a solid framework, backed with a rich theoretical foundation, for modeling 
objects and the relationships between them. More formally, a graph is a pair (V, E) where 
V is a finite set, called the vertex set, and E, called the edge set, is a binary relation on V. 
In particular, finding paths in a graph is a well defined problem that a number of efficient 
algorithms have been developed to solve. Therefore, the problem of metabolic path finding 
becomes finding a correct way to associate compounds, reactions and their relationships to 
V and E in an appropriate graph model and applying the proper path finding algorithm. 
The most commonly used graph models for representing metabolic networks are com-
pound graphs, reactions graphs, bipartite graphs and hypergraphs [65, 29]. Examples for 
each of these graph models are depicted in Figure 2.5. The graphs used are typically directed 
graphs in order to take the direction of reactions into account, but may be undirected if 
the direction of reactions is unimportant or unknown. In a compound graph, the vertices 
correspond to compounds and an edge is drawn from one compound to another if one 
compound is a substrate and the other compound is a product in a reaction. The reaction 
graph is a similar concept except the vertices correspond to reactions and an edge is drawn 
from one reaction to another if a product of one reaction is used as the substrate as the 
other reaction. Compound and reaction graphs have been used in analysis related to the 
topological properties of metabolic networks [122, 73, 51]. However, they are limited as 
they only contain information about compounds or reactions and therefore can also be 
ambiguous. That is, two different set of metabolic reactions can create the same reaction or 
compound graph [29]. For example, the graph in Figure 2.5(b) could represent two different 
reactions, one being CI —> C2 and the other being CI —> C3 instead of Rl as found in 
Figure 2.5(a). One way to eliminate the ambiguity is to add edge labels based upon the 
reactions, but a more popular approach is to use a bipartite graph to represent the network. 
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R1:C1 -+C2 + C3 
R2: C2 + C3 -» C4 + C5 
R3: C4 -• C6 
R4: C5 -• C7 
(a) 
\mJ \J %J Xj 
(b) (c) (d) (e) 
Figure 2.5 : The generic metabolic reactions, Rl , R2, R3 and R4 using the generic com-
pounds CI, C2, C3, C4, C5, C6 and C7 in (a) represented using four different graph models: 
(b) compound graph (c) reaction graph (d) bipartite graph (e) hypergraph. 
26 
In a bipartite graph representation, there are vertices representing reactions and vertices 
representing compounds. A bipartite graph is one where V can be partitioned into two 
disjoint sets, V\ and V2, such that each edge has one node in V\ and the other in V2. When 
modeling a metabolic network as a bipartite graph, the two disjoint sets correspond to the 
set of compounds and the set of reactions. There are no edges in the graph from compound 
to compound or reaction to reaction. Edges are drawn from substrate compounds to the 
reaction they participate in and from the reaction to the resulting product compounds. This 
means the bipartite graph is not ambiguous, as is the case with compound or reaction graphs. 
Hypergraphs provide another unambiguous model of metabolic networks. A hypergraph is 
still a pair (V,E), but now the edge set is no longer restricted to connecting two individual 
vertices. Instead, it contains hyperedges that can connect two arbitrary subsets of vertices. 
For modeling metabolic networks, the vertices of the hypergraph correspond to chemical 
compounds and the hyperedges correspond to the reactions. A hypergraph representation of 
metabolic network is equivalent to the bipartite representation, as a hyperedge corresponds 
to a reaction vertex in the bipartite graph [29]. 
While graph models have a number of advantages for finding pathways in metabolic 
networks, the main disadvantage is that they can contain spurious connections through 
currency metabolites. Therefore, most of the research in the last decade has been on 
developing methods and heuristics to avoid these spurious connections. A discussion of 
these approaches follows in Section 2.3.1. Another disadvantage is that graphs do not 
typically model the splitting and joining of chemical compounds, which can result in 
branched metabolic pathways. The work in this thesis overcomes these disadvantages by 
explicitly tracking the atoms in the network which helps avoid spurious connections as well 
as enables finding branched pathways. According to the current literature, there is only one 
other graph based method, discussed in Section 2.3.2, that is able to find branched pathways. 
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2.3.1 Finding Linear Metabolic Pathways 
The early 2000's saw a rise of interest in graph-based analysis of biological networks. Most 
of the work in this field has focused on identifying linear pathways, as they correspond to 
paths, as defined by graph theory, in graph representations of metabolic networks. One of 
the seminal works focused on analyzing the topology of metabolic networks and brought the 
concepts of scale-free and small world to biological networks [52]. In their work, Jeong et 
al. modeled the metabolic networks of 43 organisms, from the now defunct WIT database, 
as directed bipartite graphs. The major conclusion of this work was that topology of the 
metabolic networks are not random but rather scale-free and small-world [52]. A scale-free 
network is one whose degree distribution is characterized by a power law of the form 
P(k) ~ k~? [12]. A small-world network is one where any two vertices in the network can 
be connected by a relatively short path. 
The scale-free property of metabolic networks means that there are a few highly con-
nected compounds and most of the compounds have low degree. Coupled with the small-
world property this means that a few compounds are responsible for the overall connectivity 
of the network. Jeong et al. found that irrespective of size, all of the metabolic networks they 
tested had highly similar diameters, between 3 and 4. A diameter of a network is defined 
as the average over all shortest paths between all pairs of vertices. They demonstrated 
that by removing the highly connected compounds one at a time from the network the 
diameter of the networks increases dramatically. These properties of networks are of further 
interest because a number of real-world networks, such as the Internet and citation networks, 
appear to have similar properties [3]. A number of other papers found that other biological 
networks, such as protein-protein interaction, transcription and signaling networks also are 
scale-free and small-world and there have been number of reviews written about the subject 
[2, 13,3, 113]. 
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The small diameter of metabolic networks was especially surprising as known biosyn-
thetic and degradative metabolic pathways are typically much longer. Further investigation 
revealed that, in graph representations of metabolic networks, many of the shortest pathways 
may be biologically meaningless because they route through highly connected currency 
metabolites [73, 5, 6]. The term currency metabolites refers to compounds that take part in 
a large number of reactions, often as cofactors instead of part of the main chemical transfor-
mation, such as ATP and NADH. Therefore, while the structural analysis of the bipartite 
graph representation of metabolic networks provides a number of interesting insights, the 
actual paths found do not correspond to biochemical pathways for synthesizing or degrading 
compounds. Subsequent studies of metabolic networks attempted to correct these issues by 
either removing edges between current metabolites and reactions or the current metabolites 
themselves from the graphs [122, 98, 73, 41]. 
Wagner and Fell analyzed undirected compound and reaction graph representation of the 
metabolic network of £ coli [122]. They compared the properties of full graphs to graphs 
where ATP, ADP, NAD+, NADH, NADP+ and NADPH were removed. The mean degree 
and standard deviation of degree of the graphs dropped when the compounds were removed. 
They found that the degree distribution of the compound graph, with or without compounds 
removed, follows the power law distribution while the reaction graph did not. This highlights 
how different representations of the same metabolic network can have different structural 
properties. Additionally, they found that both graphs were small-world, with or without 
compounds removed, although the shortest paths in the graphs with compounds removed 
had slightly longer path lengths. In the work of Ma and Zeng, they analyzed the metabolic 
networks of 80 organisms, represented as directed compound graphs [73]. They manually 
examined about 3,000 reactions to determine whether the compounds involved were part of 
the main chemical transformation; if they were not, the corresponding edge was removed in 
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the graph. This resulted in more than half of the edges being removed from the graphs, but 
they still found the small-world property held for these graphs. 
The work of Arita was the first to challenge the notion of metabolic networks being small-
world and introduced the idea that "the biochemical link between metabolites ... depends on 
the conserved structural moieties in the adjacent reactions" [6], Therefore, a valid metabolic 
pathway between two compounds is redefined as a sequence of reactions that conserves at 
least one carbon atom from the starting to the target compound. In order to automatically 
identify these pathways atom mapping data is required. Arita manually created a database 
of atom mapping for over 2,500 reactions contained in the KEGG database [6, 5]. Valid 
pathways were identified by running a k-shortest pathway algorithm until the shortest path 
that conserved at least one carbon atom was found. Using the length of these pathways, 
it was revealed that the small-world property no longer held [6]. This analysis showed 
the importance of not ignoring the biochemical underpinnings of metabolic networks and 
provided evidence that graph models need to be used with care in order to find valid 
metabolic pathways. 
Biochemical intuition says that pathways which move a high percentage of atoms from 
start to finish compounds will be biologically relevant. Boyer and Viari proved that this 
problem is PSPACE-complete by formulating the problem as finding a maximal composition 
of partial injections [17], They also state, but do not prove that when a compound can 
only be used once in a pathway, the problem is NP-complete. Despite the complexity, they 
were able to develop an algorithm that found linear atom conserving pathways efficiently 
in practice, given a number of atoms to conserve and a maximum pathway length. The 
algorithm by Boyder and Viari returns all pathways less than the maximum pathway length 
that conserve the given number of atoms. The algorithm was tested with atom mapping 
data obtained by using the SIMCOMP program on data from KEGG, resulting in a network 
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containing 2920 compounds and 3721 reactions. They present two pathway results, one for 
chorismate to tryptophan, conserving 6 carbon atoms with a maximum pathway length of 
6, and the other for -D-glucose 6-phosphate to phosphoenolpyruvate, conserving 9 heavy 
atoms with a maximum pathway length of 8. Both pathway results contain the known 
metabolic pathways, along with a several other pathways. In the case of tryptophan the 
other pathways are mainly catabolic pathways, which is expected as they considered all 
reactions as reversible. In the case of glycolysis, the other pathways included reactions 
from the pentose phosphate pathway. These results provide evidence that the intuition that 
atom conserving pathways are biologically relevant may be correct. However, in the next 
few years, work on path finding in metabolic networks mostly focused on finding realistic 
linear pathways without using atom tracking, perhaps due to the theoretical complexity and 
the perceived unavailability of atom mapping data. These approaches focused on finding 
realistic metabolic pathways with minimal manual intervention. 
One approach was to use measures of structural or chemical similarity instead of explicit 
atom mapping to avoid avoid spurious connections when finding metabolic pathways 
[78, 95]. The PathMiner program uses a predefined set of 145 descriptors based on atom 
type and bond type [78]. Each compound is then represented by a vector of size 145 where 
each entry corresponds to the number of atoms or bond of each type that the compound 
contains. The cost of a transition from one compound to another is then calculated as the 
difference of the vectors for the two compounds. PathMiner uses the data from the manually 
curated KEGG pathway maps, which typically contain only the compounds involved in 
the main chemical transformation, resulting in 3890 compounds and 2917 transformations. 
PathMiner was tested on four different metabolic pathways using breadth-first and depth-
first search. As expected, it was observed that the BFS finds the shortest path in terms of 
number of reactions and the DFS finds very long pathways. Additionally, an A* search was 
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tested, using a cost function that was the sum of transition costs along the pathway. The A* 
approach showed promise, compared to BFS and DFS, but they note that due to the cost 
function, it is best used for pathways that contain small chemical modifications and may not 
perform as well on pathways that require the addition of large functional groups. 
The Pathway Hunter Tool (PHT) takes a similar approach to PathMiner by creating a 
bit vector based upon the chemical structure of a compound [95]. This was done by using 
the "fingerprinting" algorithm contained in the Chemistry Development Kit [111, 112]. The 
similarity between two compounds is then computed by combining the atom mass value 
and the Tanimoto algorithm [130]. PHT then differs from PathMiner in that it automatically 
maps substrate compounds to product compounds, instead of relying on the manually curated 
KEGG pathway maps. This mapping is done by iteratively assigning substrate-product 
pairs that have the highest similarity. The substrate-product pairs are then used to determine 
valid connections during a search of the graph. PHT does not use the similarity scores in 
the search of the graph, but rather just returns the k-shortest paths based upon the number 
of reactions in the pathway. In the article, they show that the shortest pathway that PHT 
finds, using data obtained from KEGG, from beta-D-glucose to pyruvate is of nine reactions 
in length and corresponds to the known reactions of glycolysis. However, there are no 
guarantees that PHT will find the correct mappings and if multiple substrates and products 
have high similarity it is unclear how the mapping will behave. PHT is currently available 
via a web server located at http://pht.tu-bs.de/PHT/. 
Another approach by Croes et al. avoided using chemical structures by focusing on 
the observation that currency metabolites have high degree in metabolic networks [26]. 
Therefore, they created a weighted, directed, bipartite graph where the compound vertices 
were assigned a weight equal to their degree. They built one graph from the KEGG database 
that contained 4,756 compounds and 5,985 reactions and another graph from the EcoCyc 
32 
database containing 1,348 reactions and 1,329 compounds. The weighted graph is then 
searched to find the k paths, where k is a user input, with minimal total weight, which they 
term lightest paths. They compared the resulting lightest pathways to shortest paths in the 
unweighted graph as well as shortest pathways in an unweighted graph where 36 manually 
selected currency metabolites were removed. Surprisingly, this relatively simple weighting 
scheme performed quite well in finding known metabolic pathways. 
Croes et al. introduced a quantitative performance measure for the known annotated 
pathways to the computed pathways; true positives (TP) are compounds found in both 
pathways; false negatives (FN) are compounds in the known pathway which are not in the 
computed pathway; false positives (FP) are compounds not in the known pathway which 
are in the computed pathway. Sensitivity (Sn) and positive predictive value (PPV) are used 
to calculate the accuracy (Ac); Sn = TP/(TP+FN), PPV = TP/(TP+FP) and accuracy Ac = 
(Sn+PPV)/2. They built a test set containing 56 pathways from the aMAZE database [70] 
and 104 pathways from the EcoCyc database [58]. In contrast, previous studies took more 
a qualitative approach to evaluating performance by just analyzing a handful of pathways. 
Using this measure, they found that the average accuracy for pathways from the unweighted 
graphs was less than 30%, filtering manually chosen currency metabolites increased the 
performance greatly to about 65% and the lightest paths performed the best with 85%. 
They additionally provided more in depth analysis of three metabolic pathways: heme 
biosynthesis, methionine/adenosyl-methionine biosynthesis and lysine biosynthesis. This 
analysis highlights that there is typically not just one correct metabolic pathway, especially 
when using a network constructed from reactions from multiple organisms, and that in the 
case of methionine and lysine biosynthesis feasible alternative pathways were found in the 
top five lightest pathways. 
Follow up work to the work on degree weighting by Faust et al. coupled using the 
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weighted graph with information obtained from the KEGG RPAIR database [35]. Faust et al. 
performed a qualitative analysis, based on the measures described in the previous paragraph, 
of the different combinations of parameters that can be used to construct metabolic graphs. 
They tested three types of graphs, the standard bipartite graph containing compound and 
reactions nodes, a bipartite RPAIR graph containing nodes corresponding to a RPAIR entry 
and nodes corresponding to compounds and a reaction-specific RPAIR, similar to the RPAIR 
graph, except it contains a node for each RPAIR/reaction combination. When all reactions 
or RPAIRs are considered reversible, the graph can be directed and contain two nodes 
representing each direction, or undirected and only containing one node for each reaction. 
The graphs could also be unfiltered, containing all compounds, or filtered where the 36 
currency metabolites identified from the previous work were removed. The RPAIR graphs 
could also be filtered based upon the RPAIR class, one where it contains all of the RPAIRs, 
one where only RPAIRs classified as "main" are included and one where only "main" and 
"trans" RPAIRs are included. Finally, they tested different weighting schemes, the degree 
based weighting from the previous work and weights based on the RPAIR classes where the 
node weights were based on the RPAIR class: main=l; trans=5; cofac=10; ligase=15 and 
leave=20. It should be noted that in this work, they did not explicitly use the atom mapping 
data contained the KEGG RPAIR data, but rather used it as either a way of constructing or 
weighting the graphs. 
Faust et al. then tested all feasible combinations of these parameters, 104 combinations 
in all, using a set of 55 annotated pathways from the aMAZE database and the accuracy 
score developed in their previous work. The top performing combination used the RPAIR 
graph and the degree based weighting scheme, resulting in an average accuracy of 83% 
across all pathways, 93% for E. coli pathways, 66% for S. cerevisiae pathways and 70% 
on human pathways. One of the most significant results was that the RPAIR graph always 
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produced the most accurate pathways and the degree weighting always performed better 
than no weighting, regardless of the other parameters. They also provided a more detailed 
analysis of several pathways to highlight specific examples where the RPAIR annotation 
helps to remove spurious connections in the metabolic graph. The pathfinding tools used 
in the analysis are freely available through the Network Analysis Tools web server at 
http://rsat.ulb.ac.be/neat/ [19]. 
MetaRoute combined the idea of weighting by degree along with the idea that a valid 
biochemical path should transfer at least one atom, typically a carbon, from the start 
compound to the target compound [15]. MetaRoute uses a different weighting scheme, 
termed combined weight, that takes into account both the degree of the compounds along 
the pathway and the degree of the compounds along the pathway that participate in the 
pathway's reactions. The intuition is that compounds along the pathway should have low 
degree, as in the work of Croes et al., and the other compounds involved in the reaction, 
but not in the pathway, should have high degree so that they're more likely to be available 
currency metabolites. MetaRoute also utilizes computationally computed atom mappings 
from the work of Blum and Kohlbacher [16]. These atom mappings are used to create a graph 
structure where each reaction is broken down into substrate/product pairs (5,-, Pj) where 
at least one atom is conserved from the substrate to the product. Each substrate/product 
pair is then a node in the graph, edges are created in the graph between two nodes (St, Pj) 
and (Sk, Pi) if Pj = S& and at least one atom is conserved from 5,- to S^. Pathways are then 
found by applying Eppstein's ^-shortest path algorithm to the graph using the combined 
weight. The k pathways are then filtered to only return pathways that conserve at least one 
atom from the start to the target compound. MetaRoute was tested on 137 pathways from E. 
coli and demonstrated improved performance over their previous work which used degree 
weighting instead of combined weighting. MetaRoute is freely available via a web server at 
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http://www-bs.informatik.uni-tuebingen.de/Services/MetaRoute/. 
The previous research done on using graph based methods for linear metabolic pathways 
has helped to shape the philosophy found in this thesis that it is important to explicitly 
track atoms to find biologically meaningful pathways. Atom tracking also enables the use 
of graph based methods to find branched metabolic pathways, a topic that has not been 
explored until the last few years. 
2.3.2 Finding Branched Metabolic Pathways 
Graph-based methods for finding metabolic pathways have focused on finding linear 
metabolic pathways because on the compound/reaction level it is unclear how to deter-
mine the relationships between the different pathways. However, the introduction of atom 
mapping data and atom tracking allows the algorithm to automatically identify where atoms 
are lost and gained along a linear pathway and thus this information can be used to build 
branched pathways. Branched pathways play an important role in metabolic networks as 
the atoms from the source compounds often go through separate reaction paths in order 
synthesize the final target compounds. Furthermore, branched pathways help highlight the 
relationships between different compounds and reactions that may not be as easily found 
by looking at a set of linear pathways. This may play an important role in the choice 
of metabolic pathways for applications such as metabolic engineering. An example of a 
branched pathway between sn-glycero-3-phosphocholine and L-threonine is depicted in 
Figure 2.6. The branched pathway contains two valid linear pathways, one through acetalde-
hyde and the other through glycine. However, only by realizing the two linear pathways 
interact biochemically can the full branched pathway utilized be revealed. 
A recently introduced algorithm, ReTrace, was the first to take a graph based approach 
to find branched pathways [91]. Similar to the algorithms presented in this thesis, ReTrace 
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Figure 2.6 : A branched pathway between sn-glycero-3-phosphocholine and L-threonine, 
with the chemical structures of the compounds depicted and the reactions that function as 
branch points highlighted in magenta. This pathway corresponds to a result found in Figure 
5.9. 
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achieves this by using atom mapping data to explicitly track atoms. In this formulation, 
the goal is to find a set of reactions that maximize the number of atoms that are conserved 
from start to target compound while minimizing the number of reactions. More formally, in 
the terminology of Pitkanen et al., g& is the set of reactions, si is the set of atom positions 
for all compounds, an atom mapping is a bijective relation r : & —> si x si describing 
which subtrate atoms become which product atoms. When finding pathways, a pathway is 
a subset of reaction P = r\,..., rk C <%, the set of start atoms is S, the set of target atoms 
is T and Zo is the fraction of atoms conserved by P from S to T. This gives rise to the 
main Find-Branching-Pathways problem which is definied by Pitkanen et al. as "Given 
a set of reactions, sets S,T C si, I G Z+ and w e R, find all pathways, P C j such that 
Zo(P,S,T) >w and |P| < /". Subsequently, they proved that Find-Branching-Pathways is 
NP-hard and developed ReTrace as a heuristic algorithm for finding branching pathways. 
ReTrace is so named because it first identifies linear paths that conserve at least one 
atom from start to target atoms and then recursively attempts to find linear paths that can 
be combined that conserve more atoms, thus resulting in branched pathways. ReTrace 
was tested on a atom graph built from 11,265 KEGG RPAIR entries involved in 7,781 
reactions. They provide a nice analysis of pairwise shortest distances when at least one atom 
was required to be conserved. Their results show that the distance distribution for carbon 
contains a long tail with a mean distance of 21.2, much longer than the mean distance of 8.4 
found in previous work [6]. For branched pathways, they looked at 13 compounds and found 
pathways between all pairs of the compounds. Their results demonstrate that computation 
time and number of pathways found is highly dependent on the compounds specified as the 
start and target sets. They provide a more detailed analysis of the branched pathway found 
from Glucose to 5'-inosine monophosphate (IMP). ReTrace has also been successfully used 
to reconstruct the metabolic network of Trichoderma reesei [54]. 
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The branched pathway algorithms in this thesis, developed independently, also augment 
linear pathways to find branched pathways that maximize the number of atoms conserved 
from the start to the target compound. Since because both methods use various heuristics 
and cutoffs to overcome the high complexity of finding branched pathways, the selection 
of which method to use may be dependent on the specific application or compounds being 
studied. One key difference is that the algorithms in this thesis explicitly use linear pathways 
that conserve at least a given number of atoms. In contrast, ReTrace finds pathways that 
conserve one atom and requires weighting heuristics to help find paths that conserve a larger 
number of atoms. As these methods are adopted, future work should analyze the practical 
performance of these methods to understand the affect of their heuristics and identify areas 
for improvement. 
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Chapter 3 
Finding Linear Metabolic Pathways 
This chapter presents a new algorithm for finding atom conserving linear pathways in 
metabolic networks, called LPAT for Linear Pathfinding with Atom Tracking. LPAT takes as 
input a start compound, a target compound, the minimum number of atoms to be conserved, 
the number of pathways to return, k, and a special data structure, termed an atom mapping 
graph (Gam). LPAT is then guaranteed to return the k shortest pathways between the start 
and target compounds that conserve at least a given number of atoms. Optionally, LPAT 
can utilize weighting schemes, for example those discussed in Section 2.3.1, that associate 
weights with compounds and reactions. If a weighting scheme is used, LPAT will return the 
k shortest pathways where the "length" of the path is equal to the sum of the weights of the 
nodes used in the pathway. LPAT is efficient enough that maximal atom conserving linear 
pathways can be found by starting with the number of atoms in the smaller of the start and 
target compounds and decrementing by one until pathways are found or a minimal number 
of atoms is reached. 
Several general steps are used to find linear metabolic pathways. The first is to construct 
Gam, described in Section 3.1, which contains the atom mapping information in a mini-
malistic way and whose structure important for the efficiency of the algorithm. After the 
construction of Gam, the next series of steps are performed by LPAT, as described in Section 
3.2. 
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3.1 Construction of Gam 
A frequently used representation of metabolic networks is a directed graph where there are 
reaction nodes and compound nodes and edges are drawn between the compounds and the 
reactions they participate in. However, tracking atoms through this representation typically 
results in unreasonably high computational cost, because of compounds, such as cofactors, 
participating in a large number of reactions. Therefore, the atom mapping graph, Gam, is 
built using the observation that the same atom mapping pattern between two compounds 
often appears in multiple reactions [5]. For example, ATP to ADP occurs in many reactions, 
but the atom mapping remains the same between the two compounds. When searching Gam, 
only one node representing the ATP to ADP atom mapping needs to be explored. This is 
more efficient than explicitly exploring all of the reactions containing the atom mapping. In 
practice, this representation is important to help reduce the computational cost required to 
find atom conserving pathways. 
Gam is a directed bipartite graph containing compound nodes and mapping nodes. Build-
ing Gam starts by providing a list of atom mappings between pairs of compounds and the 
associated reactions that utilize the atom mappings. For each compound, a compound node 
is added to Gam that has a unique identifier as well as a unique identifier for each of the 
atoms in the compound. A mapping node is added for each atom mapping entry and two 
directed edges are created, one from the first compound to the mapping node and one from 
the mapping node to the second compound. The mapping nodes contain atom mapping 
information, such that the atom identifiers from the substrate compound are associated with 
the atom indices in the product compound. There are can be multiple mapping nodes for the 
same pair of compounds. Reversibility is handled by adding another mapping node to enable 
the reverse direction; it has the same edges created but in the reverse direction. Typically, if 
no reversibility information is available then all atom mappings are considered reversible. If 
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reversibility information is provided, it is incorporated into Gam by only allowing the corre-
sponding edges to be added to the graph. Additionally, molecular symmetry can be handled 
by adding multiple mapping nodes that correspond to the different possible symmetries. 
The mapping information contained in Gam allows for explicit tracking of an individual 
atom through the graph. Figure 3.1 shows a small subgraph of Gam. In this subgraph, a 
linear path from C00231 to C05345 through RP00080 and RP13340 conserves three carbon 
atoms. An important property of Gam is that all mapping nodes only have one input edge and 
one output edge connected to two different compound nodes. The compound nodes have 
the same number of outgoing and incoming edges equal to the number of atom mapping 
entries they participate in. Therefore, the degree of the nodes of Gam is less than the more 
traditional compound and reaction directed graph, which in turn contributes to the efficiency 
of the path finding methods. 
3.2 LPAT: Linear Pathfinding with Atom Tracking 
LPAT begins with a depth-first exploration of Gam. The exploration, described in Section 
3.2.1, begins with the atoms of the start compound and finds all parts of the atom mapping 
graph that are reachable with at least the given number of minimal atoms. The result of the 
exploration is then used to build an auxiliary graph, described in Section 3.2.2, that has the 
property that all pathways from the start compound conserve the given number of minimal 
atoms. The last step is to run a standard k shortest path algorithms, the choice of which is 
discussed in Section 3.2.3, on the auxiliary graph and the resulting pathways correspond to 
the atom conserving linear pathways. 
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- C00197:C2 
Figure 3.1 : An illustration of a small subgraph of Gam built from KEGG RPAIR data 
containing four compound nodes and three mapping nodes. The identifiers for each node 
are in bold, the compound nodes are also labeled with the common name of the compound 
and the mapping nodes contain the mapping between the carbon atoms. The KEGG RPAIR 
database contains information for all non-hydrogen atoms, but only carbons are depicted for 
clarity. The carbons colored in blue are mapped in the mapping nodes while the green and 
pink colored carbons are not in this subgraph. 
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3.2.1 Exploration of Gam 
After the construction of Gam, LPAT begins with an exploration step that traverses Gam in a 
depth-first manner while explicitly tracking where each atom from the starting compound 
goes along the way. The exploration is a modified version of a standard depth-first search 
because the semantics of Gam are different. These semantics require that the exact set of 
atoms visited in each compound are recorded, and not just the fact that the node itself 
is visited as in traditional graph traversals. Therefore, a string containing the compound 
identifier along with an ordered list of atom identifiers is termed an atom marking. When the 
exploration moves through a mapping node, the input atom marking is used to compute the 
output atom marking based upon the mapping contained in the mapping node. The queue 
for the depth-first search then contains mapping nodes along with their input atom marking. 
For example, in Figure 3.1 the atom marking for all carbon atoms in D-xylulose 5-phosphate 
would be "C00231 C0,C1,C2,C3,C4", then taking the mapping node RP00080 would result 
in the atom marking "C00118 C0,C1,C2". 
Since each possible atom marking is considered a different state during the exploration, 
each compound node can be visited ^ I , ) times where n is the number of atoms in the 
k=m W 
compound and m is the minimum number of atoms to conserve. Theoretically, this means 
there is the potential for a combinatorial explosion in the number of states to visit during 
an exploration of Gam. One standard way to reduce the amount of exploration time is to 
limit the depth of the search. However, in practice the cost of the exploration is dependent 
on a number of interelated factors such as the number of atoms in the start compound, the 
minimum number of atoms to conserve and the connectivity of the graph. In all of the 
linear pathway experiments for this thesis, a complete exploration of Gam was obtained in a 
reasonable amount of time and space without a limit on the depth. 
The states visited during the exploration are recorded using an object containing the 
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input atom marking, the identifier of the mapping node taken and the resulting output atom 
marking is termed a transition history. Using the atom markings and transition history, we 
can now introduce Atom Tracking Depth-First Search in Algorithm 3.2.1. This search starts 
from the starting compound and explores Gam to find all reachable states that conserve the 
given number of atoms. The result of the search is a list of generated transition histories, L, 
which is then used to build an auxiliary graph. An example of how Algorithm 3.2.1 operates 
on a generic Gam is illustrated in Figures 3.2 and 3.3. 
3.2.2 Auxiliary Graph Construction 
The resulting list of transition histories, L, from the previous exploration step of Gam, 
implicitly contains all of the linear atom conserving pathways. It is an implicit representation 
because the search backtracks when it reaches a previously explored state, instead of 
explicitly storing the path consisting of the new exploration path combined with the old 
exploration path. The purpose of the auxiliary graph is to combine all of the states explored 
such that the auxiliary graph can be used as input to standard k shortest path algorithms to 
obtain the final linear pathways. The auxiliary graph can almost be thought of as a filtered 
version of Gam which only contains paths from the start compound that conserve at least 
the given number of atoms. However, Gam can not be filtered directly by the exploration 
because of the atom tracking behavior. The atom tracking causes each compound node to 
take on several atom marking states which are not represented explicitly in Gam. Therefore, 
the auxiliary graph must be constructed separately from Gam so that it explicitly contains all 
of the atom marking states and mapping nodes found during the exploration. 
The construction of the auxiliary graph begins with the resulting list of transition histories, 
L, from the previous exploration step of Gam. The auxiliary graph contains a node labeled 
with each atom marking found in L. For each transition history, a new node containing the 
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Algorithm 3.2.1 Atom Tracking Depth-First Search (LPAT) 
Input: Input Compound Atom Marking c,n, Minimum Number of Atoms to Conserve n, Atom 
Mapping Graph Gam 
Output: List of Transition Histories L 
1: V <— {cam} Set of visited atom markings 
2: S <— {} Stack of partial transition histories containing a mapping node and an input atom 
marking 
3: L ^ { } 
4: for each successor mapping node m from c,„ in Gam do 
5: Add {m, c,„} to S 
6: while S is not empty do 
7: Pop 5 from S 
8: cout <- the output atom marking of traversing the mapping node sm of s using the atom 
marking sam of s 
9: Add transition history {sam, sm, cout} to L 
10: if cout is not in V then 
11: AddcOJrftoV 
12: if cout contains n or more atoms then 
13: for each successor mapping node m from cout in Gam do 
14: Push {m, cOHr} on to S 
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M6 
C3:1 -» C2:1 
C3:2 - C2:2 
M7 
04:1 -> C5:1 
C4:2 - CS:2 
04:3 - C5:3 
C4:4 - C5:4 
C4:5 - C5:5 
C4:6 - C5:6 
Stack: 
C1 {1,2,3,4,5,6}, M1 
C1 {1,2,3,4,5.6}, M2 
Transition Histories: 
(a) (b) 
Figure 3.2 : A generic Gam is drawn in (a), the compound nodes are ovals containing circles 
representing each atom of the compound and the mapping nodes are rectangles. When 
an exploration of this Gam is started at CI , its atom marking contains all of its atoms, as 
indicated by coloring them green. The exploration then identifies all adjacent mapping 
nodes, which are colored magenta. The state of the stack and the list of transition histories 
is shown in (b). Since this is the start of the exploration there are no transition histories yet. 
The next step of the exploration is shown in Figure 3.3. 
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M1 
C1:1 -»C2:1 
C 1 : 2 - C 2 : 2 
C1:3 -> C2:3 
M4 
C3:1 -> C2:1 
C3:2 - C2:2 
C3:3 - C2:3 
M6 
C3:1 -• C2:1 
C3:2 - C2:2 
C4:1 
C4:2 
C4:3 
C4:4 
C4:5 
C4:6 
M7 
-* 
-* 
-» 
-» 
-» 
-
C5:1 
C5:2 
C5:3 
C5:4 
C5:5 
C5:6 
1 
.0©®®©©v 
Stack: 
C2 {1,2,3}, M3 
C2 {1,2,3}, M5 
C1 {1,2,3,4,5.6}, M2 
Transition Histories: 
C1 {1,2,3,4,5,6}, M1.C2 {1,2,3} 
(a) (b) 
Figure 3.3 : The next step of the exploration of generic Gam, continued from Figure 3.2. The 
first item is popped off of the stack from Figure 3.2(b) and the atom marking of CI with the 
atom mapping in Ml is used to compute the resulting atom marking of C2, highlighted in 
green in (a). The transition history generated by this traversal is added to the list of transition 
histories in (b). The adjacent mapping nodes to C2 are then added to the stack with the atom 
marking of C2, highlighted in magenta in (a) and the state of the stack is shown in (b). The 
exploration continues in this manner until the stack is empty. 
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mapping node identifier is added. Since the same mapping node can be traversed using 
different atom markings, the mapping node identifier is appended with a counter that is 
incremented every time the same mapping node is added to the auxiliary graph. Then an 
edge is drawn from the input atom marking node to the node representing the mapping node 
and then from the node representing the mapping node to the output atom marking node. 
Figure 3.4 illustrates the construction of the auxiliary graph from the generic Gam found in 
Figures 3.2 and 3.3. Figure 3.4(a) contains the resulting L from the full exploration of the 
generic Gam and Figure 3.4(b) shows the auxiliary graph constructed from this L. 
3.2.3 Finding k shortest paths 
The final step of LPAT finds the linear atom conserving pathways by using a standard 
k shortest path algorithm run on the auxiliary graph. The auxiliary graph only contains 
one node for the start compound, but it may contain several different nodes for the target 
compound with different atom markings. If a specific atom marking is desired for the target 
compound, then the corresponding node can be used as the target node for the k shortest 
path algorithm. For example, there are two different atom markings of C5 in Figure 3.4(b), 
but they can be easily merged into one node as illustrated in Figure 3.5. Typically, the atom 
markings of the target compound do not matter for linear pathway finding and so all nodes 
corresponding to the target compound are merged into one node. Then, the k shortest path 
algorithm gets as input the auxiliary graph, the node corresponding to the start compound 
and the node corresponding to the target compound and the resulting set of pathways are 
linear atom conserving pathways. 
The implementation of LPAT in this thesis use Eppstein's k shortest path algorithm [33]. 
Eppstein's algorithm was chosen because of its low computational cost, 0(m + nlogn + kn), 
where n is the number of verticies, m is the number of edges and k is the number of paths 
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f M4_0 J ( M5_0 j 
/ 
Stack: 
i f C2 {1,2,3} } ( C 4 {4,5,6} J 
Transition Histories: 
C1 {1,2,3,4,5,6}, M1, C2 {1,2,3} 
C2 {1,2,3}, M3, C4 {1,2,3} 
C4 {1,2,3}, M7.C5 {1,2,3} 
C1 {1,2,3,4,5,6}, M2, C3 {1,2,3} 
C3 {1,2,3}, M6, C2{1,2} 
C3 {1,2,3}, M4, C2 {1,2,3} 
C3{1,2,3},M5,C4 {4,5,6} 
C4 {4,5,6}, M7, C5 {4,5,6} 
(a) 
£ c 5 {4,5,6} j 
C5 {1,2,3} 
(b) 
Figure 3.4 : The resulting list of transition histories, L, from the exploration of the generic 
Gam, conserving three atoms, found in Figures 3.2 and 3.3 is shown in (a). L is then used 
to construct the auxiliary graph found in (b), with nodes created for each atom marking 
and mapping node and edges from input atom markings to the mapping node and from the 
mapping node to the output atom marking. Notice that the traversal of M6 is stored in the 
list of transition histories so that it is not visited again in the exploration, but it does not 
need to be contained in the auxiliary graph because it cannot be part of a path conserving 
three atoms. Also notice that M7 is traversed two separate times utilizing different atom 
markings, this is taken into account by appending the identifier of each mapping node with 
a counter that distinguishes the two traversals. 
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( C2 {1,2,3} J ( M5_0 j 
% ii i\mvmmmM»uun^r \mmmmmmmmmiem' immmmmmmmr ^m 
Figure 3.5 : Auxiliary graph from Figure 3.4(b) with the nodes corresponding to C5 merged 
together for finding pathways between CI and C5 conserving three carbons. This graph 
can now be used with k shortest path algorithms using "CI {1,2,3,4,5,6}" as the starting 
node and "C5" as the target node and the returned paths will correspond to linear pathways 
conserving three atoms between CI and C5. 
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to return. However, Eppstein's algorithm considers all paths, not just simple paths, and so 
the paths returned can contain cycles. For some applications, finding paths with cycles may 
be useful, but for the most part metabolic paths with cycles are undesirable. Cycles are 
especially undesirable when all reactions are considered reversible, as many pathways will 
contain many cycles from the substrates to the products and back again through the reverse 
direction. This is highly unlikely biochemical behavior and in the current implementation 
of LPAT, k is typically set to a high value and the resulting pathways are filtered to remove 
paths with cycles. Future implementations may investigate using k shortest path algorithms 
that only consider simple paths, such as Yen's algorithm that takes 0(kn(m + nlogn)) [131], 
which have slower run times but do not require the filtering step. 
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Chapter 4 
Finding Branched Metabolic Pathways 
In addition to eliminating inappropriate transitions, atom tracking identifies where atoms are 
lost and gained along a linear pathway and enables finding branched pathways. This chapter 
presents two algorithms for Branched Pathfinding using Atom Tracking (BPAT) that both 
begin by identifying linear pathways, using LPAT, between the start and target compounds. 
Due to the high complexity of this problem, as discussed in Section 2.3.2, the BPAT 
algorithms utilize different heuristics and cutoffs to identify biologically relevant pathways. 
Since BPAT-S and BPAT-M are heuristic, they can return different top ranking results. As 
further explored in Chapter 5, BPAT-S and BPAT-M both have their own advantages and 
disadvantages. 
Both algorithms take as input the atom mapping graph, Gam whose construction is 
described in Section 3.1, a correspondence between the atom mappings and the reactions 
they occur in, a start compound, a target compound and a minimal number of atoms to 
conserve and returning a set of branched pathways, ranked first by the number of atoms 
conserved and then by the total length, or weight, of the linear pathways used to construct 
it. The algorithms both begin by passing the appropriate inputs to LPAT and then take two 
different approaches for finding branched pathways from the linear pathways. The first 
algorithm, BPAT-S (S for Seed pathways), is described in Section 4.1. BPAT-S works by 
taking each linear pathway and replacing mapping nodes through which atoms are lost and 
gained with specific reactions to form seed pathways. Branches can then be added to the 
seed pathways, resulting in branched pathways. The second algorithm, BPAT-M (M for 
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Five Pathways From LPAT 
QQQQQ 
0 6 6 6 £ 
Figure 4.1 : A cartoon depicting the approaches taken by BPAT-S and BPAT-M to find 
branched pathways. The linear pathways from LPAT are represented as the colored lines 
and the circles represent the start and target compounds. BPAT-S takes each pathway in turn 
and finds new branches, represented by the narrower black lines, that can be attached to the 
linear pathway. BPAT-M does not find new branches, but rather tries to merge the linear 
pathways into branched pathways. 
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Merging), is described in Section 4.2. BPAT-M attempts to merge linear pathways together 
to form branched pathways. An high level depiction of the general approaches for BPAT-S 
and BPAT-M can be found in Figure 4.1. 
4.1 BPAT-S: Branched Pathfinding Using Seed Pathways 
This section describes how BPAT-S finds branched pathways in metabolic networks. The 
first step of BPAT-S is to use LPAT, described in the previous chapter, to obtain a set of 
linear pathways between the desired start and target compounds. The linear pathways are 
then examined to find the compounds through which atoms are lost or gained through. 
This examination gives rise to the creation of seed pathways, where mapping nodes that 
potentially lose or gain atoms are replaced by specific reactions. Potential branches are then 
identified between reactions through which atoms are lost and gained. All valid combinations 
of these branches are systematically attached to the seed pathways to obtain the resulting set 
of branched pathways. 
4.1.1 Generation of Seed Pathways 
BPAT-S starts by using LPAT to obtain a set of linear atom conserving pathways, P/. Each 
pathway in P/ will potentially give rise to a number of seed pathways. While the atom 
mapping graph, Gam, contains enough information to find linear pathways, it is missing 
information about which substrate and product compounds not along the pathway through 
which the atoms can be lost or gained. Identifying these compounds is important because 
they are the start and target compounds for potential branches. In order to obtain this 
information, the actual reactions associated with the atom mapping must be examined. 
Therefore, a correspondence is stored between mapping nodes and reactions. 
For the experiments in this thesis, the reaction data is obtained from KEGG REACTION 
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Table 4.1 : RPAIR entry RP00080 between D-xylulose 5-phosphate (C00231) and D-
glyceraldehyde 3-phosphate (COO 118). 
RPAIR ID 
RP00080 
Substrate ID 
C00231 
C00231 
C00231 
Atom ID 
C2 
C3 
C4 
Product ID 
C00118 
C00118 
coon 8 
Atom ID 
C2 
CI 
CO 
Chemical Drawing 
0 0 0 
II 1 II 
0^  ^CK ^G3^ , . 0 - f - O 
co a c« 
1 o 
0 9 
. 0 ~ - P - 0 
! 
C1 —0 
database and KEGG also provides the correspondence between RPAIR and REACTION 
entries. For example, RP00080 in Table 4.1 is associated with six different reactions in 
KEGG, which use and produce different compounds in addition to D-xylulose 5-phosphate 
and D-glyceraldehyde 3-phosphate. Two of the reactions are illustrated in Figure 4.2. In one 
reaction, D-xylulose 5-phosphate reacts with formaldehyde to produce D-glyceraldehyde 
3-phosphate and glycerone. In the other, D-xylulose 5-phosphate reacts with orthophosphate 
to produce D-glyceraldehyde 3-phosphate and acetyl phosphate. The important difference 
is that in the first reaction the CO and CI carbons of D-xylulose 5-phosphate end up in 
glycerone and in the second reaction they end up in acetyl phosphate. Hence, the starting 
compound of the branch is different depending which reaction is used. 
By using the corresponding reactions, for each p E Pi two types of mapping nodes 
are identified: loss mapping nodes (LMNs) and gain mapping nodes (GMNs). LMNs 
are mapping nodes where the atom mapping does not map all of the atoms in the input 
compound and GMNs are mapping nodes where the atom mapping does not map all of the 
atoms in the output compound. For example, RP00080 in Table 4.1 would be considered a 
LMN. 
The construction of seed pathways begins by (a) replacing each LMN in p with all 
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Figure 4.2 : The reactions R01621 (top) and R01440 (bottom) contain the atom mapping, 
RP00080, found in Table 4.1. If RP00080 was in a linear pathway, it would be considered a 
LMN, R01621 and R01440 would be two of the corresponding LRNs, with R01621 resulting 
in acetyl phosphate being the LCN and R01440 resulting in glycerone being the LCN. 
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possible corresponding reactions - called loss reactions nodes (LRNs), and (b) replacing 
each GMN in p with all possible corresponding reactions - called gain reaction nodes 
(GRNs). Since a mapping node can have multiple corresponding reactions, one seed 
pathway is created for each possible combination of LRNs and GRNs along the pathway. 
For example, since RP00080 in Table 4.1 is found in six reactions in KEGG at least six 
seed pathways would be created, each one containing one of the reactions. Depending on 
the reactions corresponding to the other LMN and GNMs, more seed pathways may be 
generated corresponding to all possible combinations of LRNs and GRNs. 
There exists the theoretical possibility of a combinatorial explosion, as the number 
of seed pathways is equal to the number of possible combinations of reactions along the 
pathway. However, in practice this has never been a problem because most pathways have 
few LMNs and GMNs, which also typically correspond to only a few reactions. Additionally, 
reactions are considered the same if the compound through which atoms could be lost and 
gained through are the same. For example, there are many reactions that include the atom 
mapping from ATP to ADR but many of these reactions are identical in that the phosphorus 
atom is lost through phosphate. Therefore, all of these reactions can be considered as the 
same LRN to reduce the number of seed pathways. 
The final step in constructing seed pathways is to attach the compound nodes through 
which atoms are lost or gained for each LRN and GRN. For each seed pathway, its LRNs are 
examined and the compound nodes through which the atoms are lost, LCNs, are identified 
and attached to the seed pathway. This is done by creating a directed edge from the LRN 
to the LCN. The GRNs are then examined and the compounds nodes through which atoms 
could be gained, GCNs, are also identified and attached to the seed pathway. This is done 
by creating a directed edge from the GCN to the GRN. The final resulting seed pathways 
contain possible attachment points for branches and are used to obtain branched pathways. 
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4.1.2 Attaching Branches to Seed Pathways 
The seed pathways can then be used as input for Algorithm 4.1.1 which returns branched 
pathways first sorted by the total number of atoms conserved and then by the total number of 
nodes. Since the algorithm is based on LPAT, as described in Chapter 3, weighting schemes 
can be easily incorporated and the results sorted by the total weight of the branched pathway. 
Additionally, utilizing multiple molecule of the start compound is a natural extension that 
can be done in two ways. One is for the user to specify the number of start molecules to use. 
Then, a new compound node corresponding to the multiple molecules is added and used 
as the start compound. This new compound node is attached to the graph by creating new 
mapping nodes, one for each molecule desired. These new mapping nodes then correspond 
to a new reaction so that each of the molecules can be used as the starting point for branches. 
This the the method used for the experimental results found in this thesis. Another, more 
general, extension is to allow any branch to start from a molecule of the start compound. 
Either way, the only thing that changes is that the LCNs corresponding to the start compound 
are considered as contributing additional atoms to the pathway when the number of atoms 
conserved are calculated. 
Algorithm 4.1.1 proceeds by examining each augmented seed pathway and obtaining 
potential branches by finding the shortest maximal atom conserving linear pathways between 
all pairs of LCNs and GCNs (lines 7-10). Then, all combinations of possible branches are 
tried systematically for attachment to the augmented seed pathway (lines 11-15). Testing 
all combinations of branches is necessary because adding a branch to an augmented seed 
pathway may affect the atom tracking down the pathway. 
The brute force nature of trying all combinations in Algorithm 4.1.1 may result in 
unreasonable running times, although this was rarely encountered in practice. This is 
partially due to the observation that the start and target compounds for branches were often 
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Algorithm 4.1.1 Find branched pathways using seed pathways (BPAT-S) 
Input: Set of seed pathways S?, Atom mapping graph Gam, max number of branches b 
Output: Sorted list of branched pathways £?>, sorted first by number of atoms conserved, then by 
total number of nodes 
1: &^{} 
2: Mb <— {} (Mj, is map between a pair of compound nodes, cx, cy and the shortest maximal atom 
conserving linear pathway in Gam from cx to cy) 
3: for each p in 5? do 
4: Q f- all compound nodes from p through which atoms may be lost 
5: Cg <— all compound nodes from p through which atoms may be gained 
6: * < - { } 
7: for each C[,cg in Q x Cg do 
8: if Mfc (ci, cg) has not yet been set then 
9: Mb(ci,cg) <— the shortest maximal atom conserving linear pathway in Gam from Q to cg 
10: AddM6(c,,c5) toB 
11: for each n = 1 to b do 
12: for each combination V of cardinality n from B do 
13: if all paths in V start from different c/ £ Q and end at different cg € Cg then 
14: /?/, 4- branched pathway created by attaching all branches in V to p 
15: Determine the number of atoms conserved along pb 
16: A d d ^ t o ^ 
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the same across a number of pathways. This observation resulted in taking extra care to 
maintain any previously computed branches in a global data structure, M&, so that branches 
can be reused for multiple pathways to reduce computation time. Experimentation also led 
to the empirical observation that trying all combinations can lead to long run times without 
substantially improving biological value. Therefore, there is an option to limit the maximum 
number of branches that can be added by b, although this was never used for the results 
presented in this thesis. 
4.2 BPAT-M: Branched Pathfinding by Merging Linear Pathways 
This section describes another algorithm, Branched Pathfinding using Atom Tracking and 
Merging (BPAT-M), for finding branched pathways by combining the linear pathways 
returned by LPAT. The idea of merging the linear pathways is motivated by the observation 
that a significant portion of time is spent finding the branches in BPAT-S, but these branches 
may already be contained in the set of linear pathways found by LPAT. Therefore, better 
performance may be achieved by merging the linear pathways into branched pathways, 
instead of re-finding the same pathways. Furthermore, BPAT-M also has the advantage that 
all pathways are considered equal, there is no division between seed and branch pathways. 
This means that BPAT-M can potentially find pathways with a wider variety topologies, as 
compared to BPAT-S where there is the central seed pathway and the branches must start 
and end on the seed pathway. 
In general, it is difficult to determine how to merge the pathways to obtain better perfor-
mance because there are typically thousands of linear pathways and testing all combinations 
would be infeasible. Fortunately, the number of possibilities is greatly reduced because of 
biochemical constraints. Only pathways that interact properly biochemically, resulting in 
more atoms conserved in the target compound, can be merged together to make a realistic 
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branched pathway. BPAT-M takes advantage of these constraints by processing the linear 
pathways to construct three data structures Q, C, and M, that are important for performance 
and their construction is detailed in the next two sections. The last section describes Algo-
rithm 4.2.1, which takes Q, M and C as inputs, along with k number of pathways to return, 
and returns k branched pathways ranked first by the number of atoms conserved and second 
by the number of reactions. There is an additional user specified parameter w for Algorithm 
4.2.1 that can be used to further limit the run time and/or storage needs as necessary. 
4.2.1 Construction of Q and C Based on Target Atom Markings (TAMs) 
A target atom marking (TAM) of a linear pathway is a set of indices corresponding to the 
specific atoms in the target compound that have been conserved from the start compound. 
So for a target compound containing six carbon atoms, linear pathways that conserve at least 
three carbons could potentially result in 42 different TAMs as ^ I ) = 42. Typically, the 
fe=3 W 
number of TAMs found is much less than the theoretical maximum number due to chemical 
constraints. Figure 4.3 displays four linear pathways from cn-D-glucose 6-phosphate to 
stachyose and their associated TAMs. TAMs play a central role in the performance of 
BPAT-M because they allow a quick way to determine which linear pathways can not be 
merged together. Two pathways can not be merged together if the intersection of their TAMs 
is nonempty, that is if they contain the same atom index or indices. This is because merging 
two linear pathways that have overlapping TAMs would require that two atoms, one from 
each pathway, would arrive at the same atom position in the target compound and this is 
physically impossible. If two pathways have disjoint TAMs, they can not necessarily be 
merged because it must be checked whether they share a common reaction, as described 
in the next section. However, if two pathways are mergable, then the TAM of the merged 
pathway is the union of the TAMs of the pathways. 
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PATH1 
RP01197 
5.4.2.2; 5.4.2.5 
Rpbiiii 
2.4.1.7 
RP00235 
2.4.1.166; 3.2.1.22; 
2.4,1.82 
PATH 2 
RP02452 
2.7.1.69 
RP00205 
2.4.1.99; 2.4.1.9; 
3.2.1.20; 2.4.1.10; 
3.2.1.48 i 
RP00235 
2.4.1.166; 3.2.1.22; 
2.4.1.82 
PATH 3 
RP02452 
2.7.1.69 
RP04656 
5.3.1.5 
RP00075 
2.4.1.5: 2.4.1.4; 
2.4.1.7; 2.4.1.125; 
2.4.1.13; 3.2.1.20; 
3.2.1.48 
PATH 4 
RP01197 
5.4.2.2; 5.4.2.5 
RP00196 
2.7.7.9; 3.6.1.8; 
2.7.7.12; 3.6.1.9; 
3.6.1.45 
UDP-glucosfr 
RP04550 
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Figure 4.3 : Four linear pathways from a-D-glucose 6-phosphate to stachyose and their 
associated carbon TAMs, as indicated by the magenta circles. 
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The ability to use the TAMs to quickly determine if pathways are not mergable motivates 
the construction of the data structure, Q, which maps a TAM to a set of linear pathways 
containing that TAM. For a particular TAM, t, this means that Q[t] returns all linear pathways 
whose TAM is equal to t. For example, using the pathways depicted in Figure 4.3, g[TAM 1] 
would return the pathways labeled PATH 1 and PATH 2. After Q is constructed, all disjoint 
combinations of the TAMs from the linear pathways are computed and stored in a list C. 
For example, for the TAMs, t\ = {0,1,2}, t2 = {0,1}, t3 = {2,3} and t4 = {4,5}, C would 
contain {^,£4}, {£2,£3^4}, {^2^3}. {h,h} and { ,^£4} as all disjoint combinations. C is then 
sorted in decreasing order by the total size of the combination. In this example, {^ 2,^ 3^ 4} 
would be first entry in C because it is of size six. Sorting C this way is important because the 
goal is to find pathways that conserve the maximal number of atoms. For each combination 
c EC, the TAMs are accessed by their indices, so if c = {t2,t3,t4}, c[l] = tj, c[2] = tj and 
c[3] = U. C is then used to dictate how the search proceeds to try and merge combinations of 
linear pathways to obtain branched pathways. Since C is sorted and the TAM of the merged 
pathway is the union of the TAMs of the linear pathways; if k pathways have been found 
and the next combination in C is smaller than the number of atoms conserved in the &th 
pathway, the search can be stopped and the pathways returned because any further pathway 
found would result in fewer atoms being conserved. The use of Q and C greatly improves 
the performance of BPAT-M by providing a quick way to identify pathway combinations 
that can potentially be merged. 
4.2.2 Construction of M 
The data structure M maps all pairs of mergable linear pathways to a tuple containing the 
reaction used to merged the pathways and the number of mapping nodes from the target 
compound that the merge point occurs at in each pathway. Two linear pathways, p\ and 
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P2, are considered mergable if they both contain a mapping node that can be replaced by 
the same reaction, r, and the atoms conserved along p\ and p2 are all incorporated into the 
same product molecule by r and subsequently into the same target compound molecule. 
Otherwise, the pathways are not mergable. This means that all mapping nodes from the 
target compound to r in each pathway must be the same. Therefore, the mergability of p\ 
and P2 starts by identifying the first different atom mapping nodes, mi in p\ and w?2 in pi, 
from the target compound and then testing whether m\ and «2 can be replaced by the same 
reaction, r, and merged. The tuple containing r, m\ and mi is called a merge point. 
All pairs of pathways that have disjoint TAMs are tested whether they are mergable; 
if they are, the corresponding entry in M is set to be the merge point, that is, M\p\ ,pz] = 
(r,mi,m2). Figure 4.4 contains two mergable pathways from ct-D-glucose 6-phosphate 
to stachyose that have disjoint TAMs. For example, since the pathways in Figure 4.4 are 
mergable, an entry for them would be created in M that contains (R00803,2,3), because 
the merge point occurs at the second mapping node from stachyose in PATH 1 and at the 
third mapping node from stachyose in PATH 2. The construction of M essentially results 
in branched pathways containing two linear pathways. The next section describes how 
BPAT-M uses M, together with Q and A, to find branched pathways containing more than 
two linear pathways by incrementally merging additional linear pathways. 
4.2.3 Finding Branched Pathways Using Q, C and M 
After processing the linear pathways to construct Q, C and M, they are given as input to 
Algorithm 4.2.1 along with k number of branched pathways to return and w. Algorithm 4.2.1 
then returns the final result of BPAT-M, the top k branched pathways it finds ranked first by 
the number of atoms conserved and then by the number of reactions. Even with the lengths 
taken to reduce the number of combinations of linear pathways that need to be tested, there 
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are still an unreasonable number and a cutoff parameter for the search, w, is introduced. 
Exactly how w limits the search is explained later in the section and its introduction means 
that BPAT-M does not guarantee finding the optimal combination, but the results presented 
in Chapter 5 demonstrate that it performs well in practice. 
Algorithm 4.2.1 works by taking each combination of TAMs c EC in turn and using 
them to build branched pathway combinations. For each combination c, the first two TAMs, 
c[\] and c[2], are used to obtain the set of associated pathways for each TAM from Q and 
all pairs of pathways are tested for mergability using M (lines 6-8). If a pair of pathways 
are mergable, then they are stored in the set of intermediate branched pathways (IBPs), 2?. 
The IBPs store a list of mergable linear pathways and their merge points. Then, for each 
subsequent TAM in C, all of the pathways associated with the TAM c[n], pq G <2[C[n]] are 
retrieved (line 9). Each pq e <2[C[«]] is then tested for mergability with each linear pathway 
in each IBP (lines 12-15), since retrieving pq from <2[C[n]] just means pqs TAM is disjoint 
from the TAMs of the pathways already contained in the IBP, which does not guarantee 
mergability. If pq is mergable with a linear pathway, p\ in IBP, that is M[pq,pi] contains a 
merge point, pq can potentially be merged with the IBP to create a branched pathway that 
conserves more atoms. However, because pi has already been merged with other pathways, 
it must be verified that the merge point between pq and pi is still valid. 
A merge point is always valid if pi has not been merged with another pathway in the 
IBP at the same mapping node it would use to merge with the new pathway, pq. However, 
if pi has been previously merged at the same point with another pathway in the IBP, the 
merge point with pq can still be valid if the reaction in the merge point of pq and pi is the 
same reaction used previously and the substrate in pq is not contained in the other pathways. 
Otherwise, the merge point is invalid. For example, if there is a reaction r that takes the 
substrate compounds a, b and c. If in the IBP pi was merged with another pathway at r with 
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pi containing a and the other containing b, then if the merge point between pi and pq is 
also at the same point but pq contains c then the merge point is still valid. However, if pq 
contained b then the merge point would now be invalid. 
If the merge point is valid, pq is merged with the IBP and the resulting branched pathway 
is stored as another IBP (line 16). Therefore, each IBP gives rise to a number of new IBPs 
equal to the number of pq that have valid merge points with the IBP. This means that there is 
a theoretical combinatorial explosion of IBPs for each C, and unfortunately, unlike previous 
situations, an unreasonable number of IBPs is typically generated. This results in the 
introduction of the parameter r to limit the number of combinations generated. After adding 
the pathways for each TAM, only the top w IBPs, sorted by number of atoms conserved 
and the sum of the length of the linear pathways, are carried over for each subsequent TAM 
(lines 17-18). As previously noted, by sorting C by the size of each combination the k 
top branched pathways can be returned before trying every combination in C if the next 
combination is smaller than the TAM of the Ath pathway (lines 3-4). 
The final way in which the run time and/or space required by BPAT-M is reduced is by 
limiting the number of pathways that are kept for each TAM in Q. This is done because it 
was observed that in some cases a few clusters can be very large and generate unreasonable 
number of IBPs, even with a low limit on r. The hope is that by removing longer pathways 
with the same TAMs, these are linear pathways that would not be contained in the final 
branched pathway set. However, future work is needed to investigate the impact of different 
limits to the number of IBPs and size of the pathway clusters. In Chapter 5, a number of 
results for branched pathways are presented that demonstrate that even with the heuristic 
limits, the search performs well and proves to be complimentary to BPAT-S. 
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Algorithm 4.2.1 Final Step of BPAT-M 
Input: Pathways organized by their TAMs, Q\ Sorted list of all combinations of disjoint TAMs, C; 
Mergable pairs of paths, M; Number of pathways to return, k; Limit on IBPs, w; 
Output: Sorted list of branched pathways SP, containing linear pathways and merge points, sorted 
first by number of atoms conserved, then by total number of nodes 
1: &>^{} 
2: for each c in C do 
3: if SP contains more than k pathways and the fcth pathway conserves more atoms than the size 
of c then 
4: Break 
5: & <r- { } //for storing the IBPs 
6: for each pair of linear pathways (puPj) in (Q[c[l]] x <2[c[2]]) do 
7: if M(pi,pj) exists then 
8: Add IBP containing Pi,Pj,M(pi,pj) to SF 
9: for n = 3 to size of c do 
10: JV 4r- ST 
11: ST^{} 
12: for each IBP P in J/ do 
13: for each linear pathway pq in <2[c[n]] do 
14: for each linear pathway pi in P do 
15: if M(pq,pi) exists and is a valid merge point in P then 
16: Add new IBP containing P merged with pq and M(pq,pi) to SF 
17: if !7 contains more than w pathways then 
18: Truncate ^ to w pathways 
19: Add all pathways in ST to gP and return 2? 
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Chapter 5 
Experimental Setup and Results 
5.1 KEGG Data Collection and Processing 
Until recently the development of automated ways to track atoms through large metabolic 
networks has been hindered by a lack of atom mapping data. Fortunately, as discussed in 
Section 2.1.1, large scale curation efforts have resulted in the increased availability of atom 
mapping data for chemical reactions. Progress has also been made in computational tools 
for automatically generating correct atom mappings, which can be used to fill in the gaps of 
the manual curation process [1, 15, 16]. The experiments in this thesis use data from the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) due to the existence of the curated 
KEGG RPAIR database [56]. Each KEGG RPAIR entry contains structural information 
for each compound, an alignment mapping atoms between the two compounds and a list of 
associated reactions [57]. 
The algorithms presented in this thesis require that there is a universal index for each atom 
in each compound. This would usually be provided by the KEGG LIGAND database that 
contains the chemical structures for each compound in a MDL Molfile with a unique index 
for each atom [42]. However, the KEGG RPAIR database was developed independently from 
the the KEGG LIGAND database and RPAIR entries contain their own KEGG Chemical 
Function (KCF) description of the structures being mapped. As such, the atom indices 
contained in the RPAIR data are not necessarily the same indices contained in the LIGAND 
data. This would not normally create a problem except that the RPAIR data is inconsistent 
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with itself, two different RPAIR entries containing the same compound may have different 
indices for the same atoms in the same compound. Since it is important to utilize as much 
of the atom mapping data as possible, several steps are taken to discard as little data as 
possible. 
The processing of the RPAIR data begins by identifying compounds whose atoms are 
consistently indexed and RPAIR entries that contain two consistent compounds are used as 
downloaded. In cases with inconsistency, an attempt is made to determine universal indices 
for the atoms using the structure in the LIGAND database as the reference structure. This 
is done by first checking whether there exists an isomorphism between the structural data 
found in the RPAIR entry and the data found in the LIGAND database. If there exists only 
one isomorphism, this mapping is used to produce a consistent RPAIR. If there is more 
than one isomorphism mapping, the RMSD is calculated between the two mappings and if 
it is equal to zero, that mapping is used. Otherwise, the RPAIR is removed from the data 
set. Additionally, any RPAIRs which consist of an atom mapping where the atom types 
being mapped do not match are discarded, except in the generic compound cases containing 
"R". KEGG contains generic compounds such as "alcohol" where the structure contains a 
"R". Mappings with generic mappings where the "R" is not mapped to a specific atom are 
included, otherwise the mapping is discarded. The overall processing of the RPAIR data 
results in discarding about one percent of the entries. 
All KEGG data used in the experiments of this thesis was downloaded on February 
10, 2010. The processed data contained 11,892 consistent RPAIR entries involving 6,002 
compounds and corresponding to 7,510 reactions. 
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5.2 Reaction Reversibility Information 
A difficulty that has plagued computational approaches to finding metabolic pathways is 
the lack of easily available information on the reversibility of enzymatic reactions. This is 
partially because the direction of the reactions is dependent on the thermodynamics of the 
system, which can change based on the environmental conditions such as pH, temperature 
and concentration. Still, many reactions are more favorable in one direction and are never 
or very rarely observed in biological conditions. Unfortunately, most metabolic databases, 
including the KEGG REACTION database, do not currently include systematic information 
about reversibility of the reactions. However, in the manually drawn KEGG pathway maps 
one will notice that a number of arrows drawn are unidirectional. Therefore, the pathway 
maps contain manually curated reversibility information. This information can be extracted 
from the XML representations of the pathway maps, distributed in the the KEGG Markup 
Language (KGML), an XML representation. 
A KGML file is obtained for each pathway map for a total of 162 files. The KGML 
language contains a tag "reaction" representing a reaction element that has two attributes: 
"name" corresponding to the reaction's KEGG ID and "type" which can be "reversible" or 
"irreversible". A reaction has two possible child elements, "substrate" and "product" which 
contain the substrate and product compounds and their ID's. All of this information is 
extracted from the KGML and used to identify irreversible reactions. However, similar 
to the RPAIR data, when a reaction occurs more than once in the pathway maps, which 
are described in Section 2.1, there are sometimes inconsistencies in the KGML data that 
need to be reconciled. The two major inconsistencies are when the substrate or products 
do not match and/or the reversibility information does not match. If the inconsistencies 
cannot be resolved, the default is to label the reaction as reversible. If only one of the either 
the substrates or products does not match previously seen reactions, then the direction of 
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the reaction is considered correct. If neither the substrates or products match, the reverse 
direction is tried and if that matches then the direction of the reaction is considered the 
opposite given. Otherwise, the reaction is considered reversible. If the substrate and products 
do match but the reversibility information does not, the reaction is then considered reversible. 
The processing of the KGML pathway maps resulted in 4,360 reactions being labeled 
irreversible. Once the reaction direction is determined, this information is then used to 
label RPAIR entries reversible or irreversible, which is used in the atom mapping graph 
construction. This is slightly complicated by the fact that one RPAIR entry can be associated 
with multiple reactions. Therefore, for each RPAIR entry all associated reactions have to 
be checked for directionality. If all of the reactions are irreversible and consistent in the 
labeling of the compounds as substrates and products then the RPAIR entry is considered 
irreversible. Otherwise, the entry is labeled as reversible. This results in 6,386 RPAIR 
entries being considered irreversible. 
5.3 Implementation Details and Hardware Specification 
The implementation was done in Java using the Chemical Development Kit [112] and the 
Java Universal Network/Graph Framework (http://jung.sourceforge.net/). All result figures 
are drawn using Graphviz (http://www.research.att.com/sw/to 
ols/graphviz/). All experiments were run on the Shared University Grid at Rice (SUG@R), 
using a single core from a 2.83GHz Intel Xeon E5440 with access to 16GB of RAM for 
each pathway. For all experiments, except where noted, the input k for Eppstein's k shortest 
paths algorithm was set to one million. 
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5.4 Linear Pathway Results 
Properly evaluating metabolic path finding methods can be a difficult task, even for linear 
pathways, because there is no standard test set. Quantitative evaluation can be especially 
troublesome when the goal is to discover previously unknown pathways or pathways 
composed of reactions from multiple organisms. To overcome these difficulties, results are 
presented on two separate test sets composed of known metabolic pathways. One is a set of 
pathways from a previous study that includes a variety of different pathways from E. coli, S. 
cerevisiae and H. sapiens [35]. The other is a set of amino acid biosynthesis pathways that 
was manually curated and constructed from a variety of sources to capture the diversity of 
pathways found in different organisms. 
The construction of the test sets and the resulting evaluation of linear pathway finding 
methods is presented and discussed in Section 5.4.1. Further probing of the performance 
of atom tracking and weighting methods is done by analyzing two specific examples that 
highlight general themes in the results. Section 5.4.2 presents results for pyruvate to 3-
hydroyxpropanoate (3HP), which is a compound of high interest as a target of metabolic 
engineering because of its numerous industrial applications and cost [49, 53]. Lastly, Section 
5.4.3 investigates using clustering techniques to understand the overall diversity of linear 
pathways found by LPAT. 
5.4.1 Evaluation Using Known Linear Metabolic Pathways 
Validation and evaluation of LPAT, as described in Chapter 3, is accomplished by utilizing 
two tests set of known metabolic pathways. One set is constructed by obtaining a test 
set of known metabolic pathways from a recent evaluation on linear pathways [35]. The 
original set was based on metabolic pathways in the aMAZE database, which provides 
cross references to KEGG, and contained 55 pathways from E. coli, S. cerevisiae and H. 
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sapiens. The set was then further processed to remove any pathways that were missing atom 
mapping data or no carbons are conserved from the start to target compounds. The amino 
acid biosynthesis pathways were also removed to avoid redundancy with the second test set. 
This resulted in 43 known metabolic pathways contained in the test set, referred to as the 
NeAT test set, after the Network Analysis Tools (NeAT) used in the previous evaluation [19]. 
A list of all of the pathways in the NeAT set can be found in Table A.l. 
While the NeAT set contains a variety of metabolic pathways, it mostly lacks alternative 
pathways between start and target compounds because it focuses on pathways from only 
three organisms. Finding alternative pathways or pathways composed of reactions from 
multiple organisms is an important application for the algorithms in this thesis. Therefore, 
a second test set, referred to as the amino acid test set, was built with the purpose of 
capturing the diversity of metabolic pathways. The amino acid set is composed of amino 
acid biosynthesis pathways because they have been well studied across many organisms and 
can often be synthesized by several different routes [81, 128]. Additionally, essential amino 
acids, such as lysine, threonine, and tryptophan, have been important successes in metabolic 
engineering efforts and are now primarily produced by engineered strains of bacteria [71]. 
The amino acid set was manually constructed by scouring textbooks, online resources such 
as KEGG and MetaCyc and literature to identify as many known amino acid biosynthesis 
pathways as possible [79, 69, 56, 58, 81, 128, 71]. The resulting amino acid set contained 71 
pathways for the 20 common amino acids between 39 pairs of start and target compounds. 
A list of all of the pathways in the amino acid set can be found in Table A.2. 
The test sets are used to evaluate four different carbon tracking methods in conjunction 
with three different weighting methods. All of the different methods are tested on the atom 
mapping graph built using the processed KEGG RPAIR data, both with the reversibility 
information as described in Section 5.2 or without, where all reactions are considered 
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reversible. The different carbon tracking methods include: 
• no carbon tracking, ignores the atom mapping data and finds the k-shortest paths in 
the graph 
• one carbon tracking, where the k-shortest paths are filtered to only include pathways 
where one carbon is conserved 
• half carbon tracking, finds k-shortest paths that conserve half of the theoretical 
maximum number of carbons (rounded up) 
For example, if the start compound contained 6 carbons and the target compound contained 
5 carbons, the max carbon tracking would find pathways that conserved 5 carbons and 
decrement by one until pathways are found. In contrast, the half carbon tracking would 
identify 5 as the theoretical maximum number of carbons and find pathways that conserved 3 
carbons, again decrementing by one until pathways are found. Both the max carbon and half 
carbon tracking utilize LPAT and will be labeled LPAT-max and LPAT-half in the following 
results. The three different weighting methods include: 
• short, where every node gets weight equal to 1 and is the same as finding the shortest 
path 
• degree, where the compound nodes are given weight equal to their degree 
• context, which is the weighting scheme used by MetaRoute as described in Section 
2.3.1 [15] 
For each combination of carbon tracking and weighting methods, the start and target 
compounds of the known pathways are used as inputs and the accuracy of the computed 
pathways is calculated using measures from previous evaluations of metabolic path finding 
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methods [26, 15, 16, 93, 35]. True positives (TP) are compounds found in both pathways; 
false negatives (FN) are compounds in the known pathway which are not in the computed 
pathway; false positives (FP) are compounds not in the known pathway which are in the 
computed pathway. For each pathway, the sensitivity (Sn), positive predictive value (PPV) 
and accuracy (Ac) are calculated as follows: 
Sn = TP/(TP + FN) 
PPV = TP/(TP + FP) 
Ac=(Sn + PPV)/2 
Positive predictive value is used instead of specificity because true negatives do not exist in 
this comparison. For the NeAT test set, each start and target compound is only associated 
with one known pathway. However, since each start and target compound can be associated 
with more than one pathway in the amino acid test set, for evaluating the accuracy, the 
known pathway is considered the union of all of the known pathways. 
Figures 5.1(a) and 5.1(b) contain the average accuracy results for the NeAT test set and 
the amino acid test set, respectively. The average accuracy values are obtained by identifying 
the pathway with the best accuracy from the top 10 computed pathways and averaging the 
best accuracies for all of the pathways in the test set.The major observation from the results 
is that all linear pathway finding methods, except for short, no carbon and short, one carbon 
perform similarly on average. For all of the path finding methods, the average accuracy was 
higher on the amino acid test set versus the NeAT test set. This is likely due to two factors, 
one is the construction of the amino acid test set to contain multiple pathways for each 
amino acid coupled with the atom mapping graph being built using data for all organisms in 
KEGG. The other factor is that the amino acid test set contains pathways that only consist 
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of one reaction and these are easy to find. While the relative accuracy of the amino acid test 
set was higher, similar conclusions can be drawn from both test sets. 
Using the reversible data from KEGG generally improved the results for all pathway 
finding methods, although the amount of improvement depended on the particular method. 
This is an expected result as information about the reversibility of a reaction eliminates 
finding "short cuts" by going through a reaction in the opposite direction it would normally 
occur. An example is the pathways found from chorismate to tryptophan. Without the 
reversibility information, the shortest path includes a series of reactions that are used in 
tryptophan degradation to make formylanthranilate and L-formylkynurenine. However, it is 
likely infeasiable for these reactions to function in this direction and the KEGG reversibility 
data includes this information. The correct biosynthesis pathway, which is one reaction 
longer than the pathway using the degradation reactions, is found as the shortest path when 
the reversibility data is used. The only exception is in the NeAT test set where the "context, 
LPAT-max" method has a slight decrease in accuracy. This is due to a decrease in accuracy for 
three pathways, L-Homoserine to 2-Oxobutanoate, Cholesterol to Glycochenodeoxycholate 
and L-Lysine to Acetyl-CoA. All of the other pathways have the same accuracy in both 
cases. This decrease occurs because the degree of the compounds change when reversibility 
information is incorporated and thus the weighting changes and the top 10 pathways change, 
in this case causing worse performance. 
The use of LPAT-half was motivated by an observed disadvantage with LPAT-max. While 
LPAT-max works in many cases, it occasionally results in long and unwieldy pathways 
because they conserve more carbons than the known pathway. Thus, the idea behind LPAT-
half is to identify pathways that transfer a significant portion of carbon atoms while allowing 
flexibility for carbons to leave the pathway. When LPAT-half is used for pyruvate to L-
leucine, the known pathway is recovered. A comparison of using the max versus half carbon 
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(a) NeAT Test Set 
AH Reactions Reversible 
Reversible Data from KEGG 
(b) Amino Acid Test Set 
Figure 5.1 : Average accuracies of linear pathway rinding methods evaluated using (a) NeAT 
Test Set and (b) Amino Acid Test Set. 
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approach, while holding the weighting scheme fixed, reveals a slight improvement for using 
the the half carbon in the NeAT test set and a larger improvement in the amino acid test set. 
A further breakdown of the differences between LPAT-max and LPAT-half performances 
can be found in Table 5.1. Only two pathways had reduced accuracy when using LPAT-half 
compared to LPAT-max, while 16 pathways had improved accuracy. This result demonstrates 
a common theme in metabolic pathfinding that while different approaches may on average 
improve the performance, it is rare that the improvement occurs across the board. 
Looking at the improvement of accuracy compared to the "short, no carbon" method, 
the results demonstrate that the improvement using LPAT-max and LPAT-half is similar 
to using the weighting schemes. Interestingly, there is no further systematic improvement 
when the weighting schemes are used in LPAT. Further analysis of the results points towards 
two factors that may account for this observation. The first is that if one excludes the short, 
no carbon and short, one carbon methods, most pathways are found with an accuracy of 
one. Therefore, the maximal performance values may be dominating the average accuracy 
values and minor differences may not be as evident. This is especially true for the amino 
acid test set, where 74% and 80% of pathway experiments find pathways of accuracy one 
without and with reversibility data, respectively. In the NeAT test set these values are lower 
at 58% and 60%, respectively. The second is that the purpose of the weighting schemes 
and the LPAT approaches is to avoid spurious connections. However, if these connections 
are already eliminated using the carbon tracking, the weighting scheme will not necessarily 
further improve the results. Additionally, if the weighting scheme causes the search to avoid 
a highly connected compound in the known pathway the carbon tracking will not correct 
this. While no clear cut examples of the weighting decreasing performance occurred in the 
test sets, a case study of pyruvate to 3-hydroyxpropanoate in Section 5.4.2 highlights the 
potential disadvantages of using weighting schemes. 
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Table 5.1 : Pathways where there was a change in accuracy when using LPAT-half versus 
LPAT-max, when both use the reversibility data. Results above the double line are from the 
amino acid test set; below the line are from the NeAT test set. Most of the pathways saw a 
large increase in accuracy when using LPAT-half versus LPAT-max. Only two pathways, 
highlighted in gray, resulted in a decrease of accuracy when using LPAT-half versus LPAT-
max^ 
Start Compound 
l.-Phenylalanine 
Pyruvate 
Pyruvate 
Pyruvate 
Pyruvate 
Pyruvate 
Pyruvate 
L-Glutamine 
L-Aspartate 
L-Lysine 
L-Lysine 
L-Lysine 
alpha-D-Glucose 6-phosphate 
L-Arginine 
L-Homoserine 
Pyruvate 
Pyruvate 
Pyruvate 
Target Compound 
[.-tyrosine 
L-Leucine 
L-Leucine 
L-Leucine 
L-Isoleucine 
L-Isoleucine 
L-Isoleucine 
L-Arginine 
L-Threonine 
Acetyl-CoA 
Acetyl-CoA 
Acetyl-CoA 
Pyruvate 
Succinate 
2-Oxobutiinoiite 
Acetyl-CoA 
Acetyl-CoA 
Acetyl-CoA 
Weight Type 
context 
short 
degree 
context 
short 
degree 
context 
short 
short 
context 
degree 
short 
short 
degree 
context 
short 
degree 
context 
Max Carbon 
Accuracy 
Half Carbon 
Accuracy 
— T — 
1 . 0.476 
0.582 
0.166 
0.546 
0.602 
0.602 
0.556 
0.505 
0.287 
0.146 
0.144 
0.37 
0.543 
0.264 
0.778 
0.274 
0.274 
0.274 
0.8 
0.752 
0.636 
0.478 
0.239 
0.597 
0.747 
0.543 
0.762 
0.686 
0.686 
0.686 
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The experiments run on the linear pathways also demonstrate the efficiency of LPAT. 
While there could be a theoretical combinatorial explosion in the search, this is never seen 
in practice and all of the test cases run on the order of minutes or less. Two bar graphs 
corresponding to the run times for both test sets using the "short, LPAT-max" and "short, 
LPAT-half" approaches can be found in Figure 5.2. While it is difficult to tease out all 
of the factors affecting run time, one general principle is that for a given start and target 
compound the run time is inversely proportional to the number of carbons tracked. This is 
made clear by sorting the run times of "short, LPAT-max", shown in Figure 5.2(a), and then 
plotting the run times of "short, LPAT-half", in the same order, shown in Figure 5.2(b). For 
almost every pathway, the runtime increased when using half the number of carbons as the 
minimal number of atoms to conserve in LPAT. In the few pathways where there this did not 
occur, such as the first bar, the first run of LPAT, given the maximum number of carbons to 
conserve, could not find any pathways. Therefore, the number of carbons was decremented 
by one and LPAT was run again to find pathways. Since the half carbon approach started 
out with less carbons, it only had to call LPAT once, resulting in shorter run times. 
5.4.2 Pyruvate to 3-hydroyxpropanoate 
While the weighting schemes have similar performance to the LPAT-max and LPAT-half 
approaches, they are heuristics that can perform poorly if the pathways require the use 
of highly connected compounds. The results of finding pathways between pyruvate and 
3-hydroyxpropanoate (3HP) demonstrate the pitfalls of relying on weighting schemes. While 
weighting schemes perform poorly on this pathway, it was chosen as a test case initially 
because the high interest in the production of 3HP using metabolic engineering approaches 
makes it an excellent test case for metabolic pathfinding approaches [49]. 3HP is used in 
a number of important industrial applications such polymer production as well as being a 
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Figure 5.2 : Run times over both test sets for (a) short, LPAT-max and (b) short, LPAT-half. 
The short, LPAT-max pathways are sorted by run time and the corresponding run times for 
the pathways using short, LPAT-half are plotted in the same order. The green represents 
the total time used for the exploration of Gam and the magenta represents the total time for 
obtaining the k shortest paths from the auxiliary graph. 
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Figure 5.3 : Known pathways for 3HP obtained from [49]. 
precursor to number of other valuable compounds such as acrylic acid or acrylamide [120]. 
Therefore, a number of pathways for 3HP biosynthesis in several different microorganisms, 
often starting from pyruvate, have been discovered and analyzed. Several of these pathways, 
constructed in microorganisms using recombinant techniques, have resulted in patents 
[115, 106]. Figure 5.3 depicts the known pathways between pyruvate and 3HP obtained 
from a recent study [49]. 
Pyruvate and 3HP were used as the start and target for all of the linear pathway ap-
proaches described in the previous section. In recovering the known pathways, the short, 
LPAT-half performed the best; three different known pathways were contained in the top 
ten pathways returned. The pathway through oxaloacetate and beta-alanyl-CoA was the 
100th pathway returned. None of the approaches were able to identify the pathways through 
alpha-alanine because the reaction between alpha-alanine and beta-alanine are not contained 
in KEGG. The LPAT-max approach did not perform as well, only finding the pathway 
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Figure 5.4 : Pathways for pyruvate to 3HP found in the top ten pathways returned by "short, 
LPAT-half". 
pyruvate aca!y-CoA •nalar'yl-ccA 
acrytov-CoA 3-WP-Ca4 3HP 
Figure 5.5 : Pathway from pyruvate to 3HP through lactate. This is the only pathway found 
using LPAT-max, as well in the top ten pathways when degree or context weighting in 
conjuction with any carbon tracking approach. 
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through lactate highlighted in Figure 5.5. This result occurs because the pathways through 
lactate conserves three carbons, the maximum amount, but the other pathways only conserve 
two carbons, due to a release of carbon dioxide. As this issue with maximizing the number 
of carbons was also observed in the test sets, it lends credence to preferring the half carbon 
approach over the max carbon approach. 
When either the degree or context weighting were used, irregardless of the carbon 
tracking approach they were paired with, the only known pathway found in the top ten 
results was through the lactate pathway, shown in Figure 5.5. Using degree weighting, not 
only were the other known pathways not found in the top ten pathways, but they were not 
found in the entire returned set of pathways. The context weighting scheme, unlike the 
degree weighting, was able to find the pathway through oxaloacetate and 3-oxopropanoate 
and caused them to be ranked 92, 88 and 58 using no, one and LPAT-half respectively. 
The context weighting scheme arguably performed better finding the pathway through 
oxaloacetate and beta-alanyl-CoA as compared to the "short, LPAT-half" approach as it 
returned it ranked 74, 71 and 43 using no, one and LPAT-half respectively. However, the 
context weighing scheme did not return the pathway through acetyl-CoA in any of the 
pathways returned using context weighting. 
Both the degree and context weighting scheme fail to find the pathway through acetyl-
CoA because acetyl-CoA is involved in a large number of reactions. For example, using the 
"degree, LPAT-half" approach, the last path in the set of 323 return pathways had a weight of 
184. However, the degree of acetyl-CoA is 264. The computed 3HP pathways demonstrate 
that when intermediate compounds are of high weight, the atom tracking approach is better 
equipped to find the known pathways. The atom tracking approach is able to avoid spurious 
connections without relying on a heuristic weighting scheme, but is flexible enough to be 
used with one if so desired. Furthermore, by utilizing atom tracking branched pathways can 
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be identified using graph-based approaches, as demonstrated in the following sections. 
5.4.3 Linear Pathway Cluster Analysis 
For most analysis of pathfinding results for linear pathways, only the top ranking ones 
are analyzed. However, it is interesting that such a large number of pathways are found 
and raises a number of questions about the pathways not manually examined. One way to 
begin answering these questions is to cluster the linear pathways to understand how similar 
or different the pathways are. Applying a clustering method requires a distance measure 
between pathways. A version of levenshtein distance, or edit distance, was chosen because 
it incorporates the notion of order along the pathway and it is relatively quick to compute 
[44]. 
To calculate the levenshtein distance between two pathways, only the compounds along 
the pathway were used and the "edits" are on the compound level. This can be thought of 
as computing the levenshtein distance of two strings representing each pathway built by 
assigning a letter to each unique compound and adding the letters to the string in the order 
they appear in the pathway from start to target compound. So in the case of KEGG, the 
"alphabet" would need to contain 6,002 letters, each one representing a different compound. 
No chemical similarity information was taken into account, each edit is considered as having 
the same weight. 
The "agnes" agglomerative clustering method from the R language was used to cluster 
the linear pathways between a given start and target compound [94], using the levenshtein 
distance as described. To validate the idea of clustering the set of linear pathways three 
examples were chosen: pyruvate to L-lysine conserving 2 carbons, G6P to L-tryptophan 
conserving 4 carbons and pyruvate to 3HP conserving 2 carbons and. The pathways from 
G6P to L-tryptophan are expected to have the least amount of variation because it is made 
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primarily through the shikimate pathway and is not known to have any major variations. 
As discussed in the previous section, pyruvate to 3HP should have more variation because 
several alternative pathways. The pyruvate to L-lysine pathways should also contain a lot 
of variation because there are two general pathways for L-lysine, through asparate and 
homocitrate, and each of those have more minor variants. The clustered distance matrices 
for each set are plotted as heat maps in Figures 5.6 for pyruvate to L-lysine, 5.7 for G6P to 
L-tryptophan, and 5.8 for pyruvate to 3HP, with red meaning the most dissimilar and blue 
meaning the most similar. 
The distance matrices for each set of linear pathways, even with a relatively simple 
clustering technique, clearly shows that there is structure in each set of linear pathways and 
that the pathways for L-lysine and 3HP are more variable than those found for L-tryptophan. 
To further assist in the interpretation of the clustered results, the known pathways were 
identified and are labeled on the distance matrices. Then, the pathways belonging to the 
same cluster as the known pathways can be extracted and manually examined and analyzed 
to understand how they relate to the known pathway. 
LPAT returned 318 pathways conserving 2 carbons from pyruvate to lysine and they were 
all used in the cluster analysis. The clustering of pyruvate to L-lysine pathways is illustrated 
in Figure 5.6 and has a relatively clear interpretation when the known pathways are labeled. 
Even without the known pathway labels, the distance matrix reveals that there are two major 
classes of pathways, which then have variations within them. Using the known pathways, 
it is found that the large cluster in the upper right of the distance matrix corresponds to 
pathways related to the aspartate pathways. The middle, smaller cluster corresponds to 
pathways related to the homocitrate pathway. The other small clusters appear to contain 
pathways that take very long routes between pyruvate and asparate or homocitrate. 
LPAT returned 14,533 pathways conserving 4 carbons from G6P to L-tryptophan and the 
A§P$B 
Figure 5.6 : Clustered distance matrix for 318 pathways found using LPAT from pyruvate 
to L-lysine that conserves at least two carbons. ASP 1-4 corresponds to the four known 
pathways through aspartate and HC 1-3 corresponds to the three known pathways through 
homocitrate. 
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top 1,000 pathways were taken for the cluster analysis. The clustered distance matrix for the 
tryptophan pathways, illustrated in Figure 5.7, reveals that there is a high level of similarity 
between the pathways. This is the expected result because tryptophan is not known for 
having a wide variation of biosynthetic pathways. The known tryptophan biosynthesis 
through the shikimate pathway is labeled on the distance matrix and it belongs to the smaller 
cluster in the top right. Inspection of the pathways belonging to the larger cluster in the lower 
left indicates that they mostly correspond to pathways that find a two reaction shortcut from 
3-dehydroshikimate through protocatechuate and 4-hydroxybenzoate to chorismate; rather 
than the four reactions typically utilized by the shikimate pathway from 3-dehydroshikimate 
to chorismate. 
The top 1,000 pathways out of 1,464 from pyruvate to 3HP conserving 2 carbons, found 
by LPAT, were used for the cluster analysis. The resulting clustered distance matrix is 
illustrated in Figure 5.8. While there are identifiable clusters around each of the known 
pathways, the clustered distance matrix for 3HP is not as well structured as the ones for 
the lysine and tryptophan pathways, and thus the interpretation is not as clear. This result 
may be due to several different factors such as, the 3HP pathways may not be as well suited 
for agglomerative clustering, the distance measure, the increased number of pathways used 
for clustering or there really are many distinct pathways for making 3HP. Initial manual 
inspection seems to indicate that there is likely a better clustering of the pathways than is 
provided by the agglomerative pathways using the levenshtein distance. For example, many 
of the pathways containing acetyl-CoA that appear similar are not clustered together, which 
may be the cause of in the relatively unstructured clusters in the lower left. 
The initial clustering results presented in this section should indicate that it may be 
worthwhile to analyze the resulting linear pathways as a whole, instead of just inspecting the 
top ranking pathways. By clustering the pathways, interesting patterns and pathways may be 
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Figure 5.7 : Clustered distance matrix for 1,000 shortest pathways found using LPAT from 
G6P to L-tryptophan that conserves at least four carbons. TRP corresponds to the known 
tryptophan pathway through shikimate. 
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Figure 5.8 : Clustered distance matrix for 1,000 shortest pathways found using LPAT from 
pyruvate to 3HP that conserve at least two carbons. A-CoA corresponds to the known 
pathway through acetyl-CoA, OA 1 corresponds to the known pathway through oxaloacetate 
and 3-oxopropanoate, LA corresponds to the known pathway through lactate and OA 2 
corresponds to the known pathway through oxaloacetate and beta-alanyl-CoA. 
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revealed that would not have been found by examining each pathway individually. While it 
is difficult to tease out all of the different properties that the cluster analysis may reveal, the 
analysis lends itself well to interactive inspection of the resulting set of pathways as a whole 
and may be important for use in future visualizations. Additionally, there are many clustering 
methods and distance measures to choose from and one future direction, highlighted by 
the 3HP case, is to study the affect of using different methods and measures. Furthermore, 
extending the cluster analysis to branched pathways is likely to provide interesting results, 
but what distance measure to use for branched pathways is an open question and provides 
fodder for future work. 
5.5 Branched Pathway Results 
Due to the emphasis on finding linear pathways in metabolic networks, there are very few 
test cases for branched metabolic networks in the literature. Therefore, the performance of 
the branched pathway finding algorithms is evaluated on a manually selected set of branched 
metabolic pathways. The pathways were selected based on biological interest, especially 
target compounds with industrial or medical applications, and how well studied they are 
to enable evaluation of the quality of the pathways returned by the algorithms. All of the 
pathways were tested with both BPAT-S and BPAT-M, described in Chapter 4, utilizing the 
reversibility data from KEGG as described in Section 5.2. A qualitative analysis is presented 
for the computed pathways based on what is known about the functioning of the branched 
pathways. For a number of pathways, a-D-Glucose 6-Phosphate is used as the starting 
compound because it is what D-Glucose, a common carbon source, is converted into upon 
being imported into the cell. A list of the start and target compounds tested, along with the 
number of carbons conserved and the total size of the top ranked pathway found by BPAT-S 
or BPAT-M can be found in Table 5.2. The resulting pathways found by BPAT-S and BPAT-
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Table 5.2 : Branched pathways, listed in the order they appear in this section, with the 
number of carbons conserved and the total size of the top ranking pathway returned by 
BPAT-S or BPAT-M. 
Start Compound 
Sn-glycero-3-
phosphocholine 
Chorismate 
G6P 
G6P 
G6P 
G6P 
G6P 
G6P 
G6P 
G6P 
G6P 
Target Compound 
L-threonine 
(5)-norcoclaurine 
Stachyose 
L-Tryptophan 
(-)-Carvone 
Inosine 
Monophosphate 
Streptomycin 
Penicillin 
Cephalosporin C 
Erythromycin 
Lycopene 
BPAT-S Top Pathway 
Number of 
Carbons 
Conserved 
4 
16 
24 
11 
9 
8 
14 
9 
15 
34 
21 
Total Size 
10 
10 
15 
28 
37 
24 
36 
30 
48 
95 
102 
BPAT-M Top Pathway 
Number of 
Carbons 
Conserved 
4 
16 
24 
n/a 
6 
6 
12 
6 
9 
33 
24 
Total Size 
10 
10 
15 
n/a 
26 
22 
23 
21 
39 
86 
136 
M demonstrate the ability of the algorithms to find known branched metabolic pathways 
and highlight a number of biologically interesting properties. The results sometimes contain 
biologically unrealistic reactions, likely due to both the high computational and biological 
complexity, but this provides inspiration for future improvements to the algorithms. 
Unless otherwise specified, BPAT-S was used without limits on the number of branches 
for each seed pathway; BPAT-M was run with r set to 1,000 and the number of pathways 
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associated with each target atom marking was limited to 5,000. In all of the branched 
pathway figures, compound nodes are ovals, mapping nodes are boxes containg the KEGG 
RPAIR ID and associated EC numbers and reactions are diamonds containing the KEGG 
REACTION ID and associated EC numbers. Each edge in the branched pathway figures 
corresponds to one molecule, for example if there are four edges from G6P that means 
that the pathway utilizes four molecules of G6P. Many of the pathways are long and have 
been split into two in order to fit on the page better, in these cases numbers are provided 
on the figures to help follow the pathways. The following results are roughly sorted by the 
complexity of the pathways, from least to most complex. The section concludes with a 
discussion of the branched pathway run times. 
5.5.1 Sn-glycero-3-phosphocholine to L-threonine 
Threonine is an essential amino acid primarily manufactured by using engineered strains 
of bacteria, and therefore there has been a major focus toward improving the yield [71]. A 
strategy to increase yield may include using pathways which transform degradation products, 
which otherwise might be lost, into the desired product. Sn-glycero-3-phosphocholine is 
a common degradation intermediate of triglycerides containing eight carbons [47]. Figure 
5.9 depicts two resulting branched pathways from the BPAT algorithms starting with sn-
glycero-3-phosphocholine to threonine which contains four carbons. In this case, both 
BPAT-S and BPAT-M returned the same pathways for the top ranked pathways. BPAT-S was 
given as input to conserve at least two carbons from start to finish and generated 29661 seed 
pathways, with the shortest seed pathway containing six reactions. The linear pathways used 
by BPAT-M also conserved two carbons, resulting in three different target atom markings 
and only one mutually exclusive combination. 
Many of the resulting branched pathways split sn-glycero-3-phosphocholine into sn-
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Figure 5.9 : The solid edges shows the known pathway, containing 11 reactions, ranked 
third in both the BPAT-S and BPAT-M results. The solid pathway is the shortest pathway for 
sn-glycero-3-phosphocholine to threonine, containing 10 reactions. 
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glycerol-3-phophate and choline, which begin paths that conserve two carbons and end 
at acetaldehyde and glycine, which then join to make the four carbon threonine. This 
general branching scheme is an expected result and no linear pathways were found that 
conserved all four carbons. The top ranked result is depicted by the dashed edges in Figure 
5.9. This result takes an unusual, likely infeasible, shortcut through acetyl phosphate. The 
reaction from acetyl phosphate to glycine is only observed in the reverse direction, but 
this is not captured by the reversibility information because the reaction is not contained 
in any of the pathway maps. However, the reaction from betaine to acetyl phosphate is a 
feasible reaction that may not typically be considered and could lead to other interesting 
pathways. Therefore, interesting paths and reactions may be automatically revealed that 
might normally not be foremost to those familiar with specific subpathways. Additionally, 
the known pathway from choline to glycine via demethylation is in the next longest set 
of pathways, with 11 reactions, and is depicted by the solid edges in Figure 5.9. The 
pathway from sn-glyerol-3-phosphate to acetaldehyde demonstrates the difficulty in finding 
the balance between finding unusual but likely shortcuts and very unlikely shortcuts. In this 
pathway, most likely pyruvate is generated from glycerone phosphate via glycolysis instead 
of through methylglyoxal. However, the overall scheme returned by the branched pathway 
search is correct and potential ways to help address shortcuts around standard pathways like 
glycolysis are discussed in the last chapter. 
5.5.2 Chorismate to (S)-norcoclaurine 
(5')-norcoclaurine is a key intermediate in the formation of benzylisoquinoline alkaloids, 
leading to more complex molecules such as morphine and codeine [80]. Chorismate, 
produced by the shikimate pathway, is an important precursor for a number of aromatic 
secondary metabolites, including (S)-norcoclaurine [50]. Each molecule of chorismate 
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contains 10 carbons and (5)-norcoclaurine contains 16 carbons. Both branched pathway 
searches conserve 7 carbons and BPAT-S is given two molecules of chorismate as the start 
compound. This resulted in 1534 seed pathways of length ranging from 4 to 14 reactions. 
The merge pathway search identified 6 different target atom markings which resulted in 5 
different mutually exclusive combinations. The top four ranked branched pathways found 
by both BPAT-S and BPAT-M correspond to the four known pathways for the synthesis of 
(S)-norcoclaurine. An illustration of these pathways can found in Figure 5.10. 
All of the pathways share the same path from chorismate to (S)-norcoclaurine through 4-
hydroxyphenylacetaldehyde, which is the shortest linear pathway. The other branch through 
dopamine is two reactions longer and much further down in the list of linear pathways. This 
means that these pathways may be missed if just the shortest linear pathways are reviewed. 
However, by searching for branched pathways these longer pathways are incorporated into 
the branched pathway and rise to the top of results over other unlikely linear pathways. This 
illustrates that identifying branched pathways may help to eliminate undesirable pathways 
and reveal important relationships. 
5.5.3 a-D-Glucose 6-Phosphate to Stachyose 
Stachyose is part of the raffinose family oligosaccharides (RFOs), which are found in many 
plant species. RFOs can be used for carbon transport and storage and can make up 25-80% 
of the dry weight of certain plants [110]. Notably, raffinose and stachyose are found in 
high concentration in soybeans, an important staple crop [30], Other functions of RFOs 
are unclear, but studies have indiciated that they may act as protective agents for seeds 
and against cold temperatures [118, 10]. RFOs have have traditionally been perceived as 
anti-nutritional because humans and other monogastric organisms lack the enzymes to break 
them down. However, it has been suggested that RFOs be beneficial to gut flora [117]. 
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Figure 5.10 : The top four pathways for two molecules of chorismate to (S)-norcoclaurine, 
as identified by both BPAT-S and BPAT-M, merged together with the dashed lines showing 
how the pathways differ. 
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Additionally, outcome of lung transplantation was improved when raffinose was included in 
the lung storage solution, although the specific mechanisms are still being studied [37]. 
The starting compound for the stachyose branched pathway search was chosen as a-D-
Glucose 6-Phosphate (G6P), even though the pathway is typically viewed as starting from 
sucrose. The top ranking pathway returned using either BPAT-S or BPAT-M was the same 
and is depicted in Figure 5.11. The computed pathway corresponds to the known stachyose 
biosynthesis pathway. While the pathway used to produce sucrose may vary in different 
organisms, the top ranked pathways also primarily vary in the paths from G6P to sucrose. 
The stachyose pathway is the most topologically complex pathway where the top ranking 
results from the merge and seed approaches are the same. Both algorithms were given as 
input to conserve at least 3 carbons for the linear pathway search. BPAT-M identified 14 
different target atom markings in the linear pathways, resulting in 19 mutually exclusive 
combinations. BPAT-S started from four molecules of G6P and tested 8746 seed pathways 
containing 4 to 11 reactions. 
5.5.4 a-D-Glucose 6-Phosphate to L-Tryptophan 
Tryptophan, similar to threonine, is an essential amino acid mainly produced by microbial 
fermentation [71]. The tryptophan biosynthesis pathway is relatively complex, with a 
number of places where carbons are lost and gained along the way. BPAT-S was initialized 
with two molecules of a-D-glucose 6-phosphate (G6P). The minimum number of carbons to 
conserve for the linear pathways was 4, resulting in 14079 seed pathways of length between 
13 and 21 reactions. BPAT-M was tried with 3 and 4 carbons to conserve, but neither search 
resulting in any returned branched pathways. The lack of resulting branched pathways 
occurs because the known pathway conserves four carbons through the shikimate pathway, 
which is relatively long, with carbons being added three carbons along the way. Therefore, 
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Figure 5.11 : Top ranking pathway returned by both BPAT-S and BPAT-M from G6P to 
Stachyose, with the linear pathways conserving 3 carbons. 
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the search with four carbons results in linear pathways that go through the shikimate pathway 
and have the same target atom marking, and thus cannot be merged. When BPAT-M uses 
3 as the minimal number of carbons to conserve, the linear pathways found are so much 
shorter that the shikimate pathway is not in the set of linear pathways returned and again 
none of the pathways can be merged. This demonstrates how the performance of the two 
approaches can widely vary based on the underlying structure of the metabolic pathways. In 
this case, the tryptophan pathway is more easily discovered by the seed pathway approach. 
The results for the tryptophan pathway are greatly improved by using the reversibility 
information. When considering all reactions reversibile, there are a number of "shortcuts" 
revealed by the search. Many of these shortcuts utilized reactions from tryptophan degrada-
tion that are unlikely to occur in the direction used by the pathway, such as ones through 
L-formylkynurenine to tryptophan and catechol to anthranilate. However, the top ranked 
result returned by BPAT-S takes a shorter route from 3-dehydroshikimate to chorismate that 
is 3 reactions long, rather than the standard 4 reactions of the shikimate pathway. The shorter 
route uses a reaction from 4-hydroxybenzoate to chorismate that is drawn as reversible on 
the KEGG pathway maps, but primarily goes from chorismate to 4-hydroxybenzoate. 
The shortest pathway that utilizes the reactions in the standard shikimate pathway is 
ranked forth in the returned pathways, but this pathway utilizes a degradation reaction that 
typically uses tryptophan as the substrate in the reverse direction as an attachment point 
for a branch. Therefore, the best result in the top ten pathways returned by BPAT-S is 
the seventh result, which captures major features of the known pathway, and is depicted 
in Figure 5.12. As with other results, the two molecules of phosphoenolpyruvate would 
typically be created via glycolysis, but here they are created by a different scheme because 
pathways conserving the same number of carbons are ordered by length. Additionally, only 
one molecule of G6P would be required which cannot be found because the seed pathway 
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approach currently only finds branches off of the seed pathway. At the same time, this result 
illuminates a number of interesting properties of the tryptophan pathway, such as serine and 
5-phospho-a-D-ribose 1-diphosphate both can be made from compounds further upstream. 
These complex relationships, automatically discovered by the algorithm, are of importance 
for metabolic pathway analysis and design and may not typically be considered. 
5.5.5 a-D-Glucose 6-Phosphate to (-)-Carvone 
Plants have evolved to produce a wide variety of secondary metabolites, often used as 
defense mechanisms to against herbivory or infection [14]. Many of these metabolites 
have medicinal and other important uses and thus are the target of metabolic engineering 
approaches to produce them on a larger scale. The monoterpene (-)-carvone is a compo-
nent of spearmint essential oil and has potential antimicrobial, anticancer and insecticial 
effects [88, 135, 66]. The known (-)-carvone biosynthesis pathway functions by combining 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) to form geranyl 
diphosphate. IPP and DMAPP can be produced either by the mevalonate (MVA) pathway 
or the methylerythritol phosphate (MEP) pathway, which was more recently discovered 
[72]. The MVA pathway is known to function in eukaryotes, archeabacteria and in the 
cytosol of plants and the MEP pathway is known to function in eubacteria, green algae and 
chloroplasts of plants [64]. Three more reactions then transform geranyl diphosphate into 
(-)-carvone, which contains 10 carbons [74]. The enzyme forming geranyl diphosphate and 
three enzymes that subsequently drive the chemical reactions to form (-)-carvone have been 
succesfully installed into E. coli in a study to understand it's capability to produce foreign 
metabolites [20]. 
BPAT-S and BPAT-M were used to find the (-)-carvone biosynthesis pathway by giving 
as the start compound a-D-Glucose 6-Phosphate, (-)-carvone as the target compound and 3 
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as the minimal number of carbons to conserved. This resulted in 21976 seed pathways for 
BPAT-S ranging in length of 14 to 21. With the default limits on the number of pathways in 
each target atom marking cluster and r for BPAT-M, the search would run out of memory 
and the results were obtained by setting r to 500 and limit the number of pathways in each 
cluster is 2500. BPAT-M identified four different target atom markings from the linear 
pathways that resulted in three different mutually exclusive combinations. 
The resulting branched pathways for (-)-carvone are the first example where both BPAT-
S and BPAP-M find branched pathways but the resulting top pathways are different. The 
BPAT-S pathway contained the MEP pathway to make DMAPP and this is used as the 
seed pathway, the MVA pathway is found as a branch to make IPP. However, the branch 
is only realistic from acetoacetyl-CoA. This is because acetoacetyl-CoA contributes four 
carbons to isopentenyl disphosphate through the mevalonate pathway and the branch tries 
to find a path of four carbons from G6P. Therefore a long, unrealistic linear pathway is 
found that does conserve four carbons instead of the more realistic branched pathway where 
acetoacetyl-CoA is synthesized by two molecules of acetyl-CoA. On the other hand, the top 
ranking pathway from BPAT-M only utilizes the MEP pathway, as it is the shorter of the 
two pathways, to make both IPP and DMAPP. Overall, this is a more realistic pathway, but 
it does not reveal the variety of pathways that can be used like the BPAT-S result does. 
5.5.6 a-D-Glucose 6-Phosphate to Inosine Monophosphate 
Inosine monophosphate (IMP) is an important intermediate in the formation of purine 
nucleotides and nucleosides. The de novo biosynthesis of IMP from glucose proceeds 
by first forming the ribose component (PRPP) from D-ribose 5-phosphate, a product 
of the pentose phosphate pathway and incrementally building the purine ring from a 
number of donor compounds, with glycine contributing the largest component of two 
105 
Pinytfr»!JhSorogi;jE 
D-Erythrose 4-piiasph3: 
.RPQI735I 
• 2.5 1.54 = 
1 i _ __ 
2-Def-.ytiro-3-deu*y-
no-heptonate 7-phosphate 
TI:: 
i SF02749 i 
i 4.2.3 4 X 3-Dehydroquinats } 
RP02750 
4.2.1.10 
;x 
x 
Giyccone phosphate 
RP01239! ..-'' O-Gfycerayehyde 
| 4.2 5.3 \ \. 3-phosphate 
J 
Methylglyoxal ; 
:RP05238 
2.7 7.60 
_::x: 
:n Li 
Dffrsetiiyialt.f diphosphate 
3-H y drc< y - 5-oxohe* ancy I- C oA 
;St-3-Hy(Jfoxyljutanoyl-CDA 
T 
RPC0314 : 
' 1 1 1.35: 1 1.1.157 -
stoacetyi-CoA 
i R •- 5- Phos pho m eva! anati 
:RP02373 
: 2.7.4.2 
__zr: 
r-5-Oiptiosphorrn 
Iscpentenyl diphosphate 
i.,2 3.5-"!etrahydroxyben2 
•ranyl diphosphab 
X L 
,..__!_ 
Phlcraglucinol 
:r 
Figure 5.13 : Top ranked pathway returned by BPAT-S for G6P to (-)-Carvone, with the 
linear pathways conserving 3 carbons. 
106 
2-C-Methyl-D-erythritol 
4-phosphate 
RP05238 
2.7.7.60 
4-(Cytidine 5'-diphospho) 
2-C-methyl-D-erythritol 
RP05239 
2.7.1.148 
2-Phospho-4-(cytidine 5'-diphospho)-
2-C-methyl-D-erythritol 
RP05245 
4.6.1.12 
T T 
2-C-Methyl-D-erythritol ~~~\ 
2,4-cyclodiphosphate / 
RP05456 
1.17.7.1 
l-Hydroxy-2-methyl-2-butenyl 
4-diphosphate 
z \ 
RP05457 
1.17.1.2 
Figure 5.14 : Top ranked pathway returned by BPAT-M for G6P to (-)-Carvone, with the 
linear pathways conserving 3 carbons. 
107 
carbons and one nitrogen [79]. The de novo incremental construction begins with 5-
phosphoribosylamine and proceeds through 5'-phosphoribosylglycinamide (GAR), 5'-
phosphoribosyl-N-formylglycinamide(FGAR), 2-(formamido)-Nl-(5'-phosphoribosyl)acetamidine 
(FGAM), aminoimidazole ribotide (AIR), l-(5-phospho-D-ribosyl)- 5-amino-4-imidazolecarboxylate 
(CAIR), l-(5'-phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole (SAICAR), 
l-(5'-phosphoribosyl)-5-amino-4-imidazolecarboxamide (AICAR) and l-(5'-Phosphoribosyl)-
5-formamido-4-imidazolecarboxamide (FAICAR) which is made into IMP. Plants, animals 
and microrganisms all perform de novo synthesis of IMP in a similar manner [136]. In 
addition to the de novo pathway, because of the importance and energenic costs of synthe-
sizing purine nucleotides and nucleosides, there are a number of purine salvage pathways 
that go through IMP [83]. These salvage pathways makes finding the de novo pathway a 
challenging case for computational metabolic pathfinding methods. 
In the recent work by Pitkanen et al., the ReTrace algorithm is tested on the IMP pathway, 
using D-glucose as the start compound [91]. The presented pathway found by ReTrace 
has a general branching scheme that combines hypoxanthine and D-ribose 5-phosphate to 
form IMP. However, this corresponds to a known salvage pathway and is not the de novo 
pathway, which the authors note that ReTrace had difficulty finding. While the hypoxanthine 
pathway is a valid branching scheme, it is unlikely to be the one from glucose. Furthermore, 
the reactions in the depicted branched pathway between glycine and hypoxanthine are 
typically degradation reactions that would proceed in the opposite direction needed by the 
computed pathway. This occurs because no reversibility information was included when 
testing ReTrace and demonstrates the importance of using reversibility information. Since 
BPAT-S and BPAT-M are tested using reversibility information it is impossible to do a direct 
comparison with the ReTrace results. 
For the IMP pathway, BPAT-S obtained better results than BPAT-M. The methodology of 
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BPAT-S enables it to start with a seed pathway for the ribose component and then search for 
a branch that corresponds to the construction of the purine base. BPAT-S used 25310 linear 
pathways ranging in length from 5 to 13 reactions. The top ranked pathway found by BPAT-
S is depicted in Figure 5.15. In this pathway, due to the use of reversibility information, 
one of the branches contains the proper sequence of reactions through glycine to AICAR. 
However, because the original seed pathway utilized a reversible salvage reaction, a strange 
connection occurs at the join point of this branch. Typically AICAR already has the ribose 
component incorporated, but in order to attach the branch, the ribose component is removed 
from AICAR to make 5-amino-4-imidazolecarboxyamide, which is then combined with 
PRPP from the seed pathway to make FAICAR. 
BRAT-M was thwarted by the fact that there are a number of short salvage pathways that 
conserve carbons from G6P to IMP through the ribose component and therefore the set of 
linear pathways found by LPAT do not contain the pathways that build the purine base of IMP 
BPAT-M was only able to find branched pathways when it used one carbon as the minimal 
number of atoms to conserve. When conserving one carbon, BPAT-M found 14 different 
target atom markings resulting in 190 different mutually exclusive combinations. The top 
ranking result from BPAT-M conserving one carbon is depicted in Figure 5.16. This pathway 
contains the same seed pathway used by BPAT-S to find the pathway in Figure 5.15 and also 
the pathway through formate which contributes one carbon. The pathway through formate 
is found in both the BPAT-S and the BPAT-M result and is interesting because the standard 
pathway for IMP biosynthesis is folate dependent, typically 10-formyltetrahydrofolate, 
as the source for the formyl group added to AICAR to form FAICAR [79]. However, 
archea perform this reaction without folate or modified folates and utilize formate instead 
[129, 134]. The automatic finding of the formate reactions from archea demonstrates how 
searching over all organisms can retrieve interesting or non-standard reactions that might 
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not be considered otherwise. 
The IMP biosynthesis pathway underscores the challenges that branched pathway finding 
algorithms face because of the complexities and nuances that occur in nature. The results 
of BPAT-S show that a number of these challenges can be overcome to produce reasonable 
results, but there is still room for future improvement as discussed in the final chapter of this 
thesis. The IMP pathway is particularily difficult because its synthesis is highly intertwined 
with a number of important compounds. Both BPAT-S and BPAT-M perform much better on 
the rest of the pathways included in this thesis because, while the pathway topology may be 
more complicated, they are secondary metabolites. 
5.5.7 a-D-Glucose 6-Phosphate to Streptomycin 
Quite a bit of research has been done to to understand and characterize the biosynthetic 
pathways related to antibiotic production, which coupled with their complex topologies 
makes them good test cases for branched pathway finding. Streptomycin is an aminoglyco-
side antibiotic that was isolated in the 1940s and subsequently became the first antibiotic 
treatment for tuberculosis [84]. Streptomycin, along with the majority of clinicially useful 
antibiotics, are synthesized by bacteria in the genus Streptomyces that primarily live in 
soil [126]. The pathway for streptomycin biosynthesis is known to be composed of three 
major pathways resulting in streptidine 6-phosphate, dTDP-L-dihydrostreptose and NDP-N-
methyl-L-glucosamine. The three compounds are incorporated in two sequential reactions 
to form dihydrostreptomycin 6-phosphate, which then becomes streptomycin via two more 
reactions [38]. 
BPAT-S and BPAT-M are used to find the streptomycin biosynthesis pathway using G6P 
as the starting compound and conserving at least three carbons. BPAT-S used 73749 linear 
pathways identified by LPAT ranging in length from 10 to 18 reactions. BPAT-M found five 
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different target atom markings that resulted in six different mutually exclusive combinations. 
The top ranking pathways for BPAT-S and BPAT-M are illustrated in Figures 5.17 and 5.18, 
respectively. The top ranking pathways found by both of the searches contains the known 
pathways to streptidine 6-phosphate and dTDP-L-dihydrostreptose and subsequently to 
streptomycin. However, the pathway to NDP-N-methyl-L-glucosamine is missing because 
it has not been well characterized experimentally and thus not contained in the KEGG 
REACTION database. Therefore, any search method using the KEGG data would fail to 
find this pathway and finding the pathway containing the other two pathways is the best that 
one could expect. 
BPAT-S additionally identifies the use of arginine in the synthesis of streptomycin. In 
each reaction, the amidino group of arginine, containing one carbon, is attached to the 
precursor compound of streptomycin. While the pathways from G6P to arginine shortcut 
through C02, the use of arginine is correct. BPAT-M does not find these branches because 
they only conserve one carbon and thus are not contained in the original set of linear 
pathways. This difference between BPAT-S and BPAT-M is a consistent theme through the 
antibiotic biosynthesis pathway test cases. 
5.5.8 a-D-Glucose 6-Phosphate to Penicillin 
Penicillin is a widely used beta lactam antibiotic that is synthesized by filamentous fungi 
and its discovery is an important landmark in the development of the biotechnology industry 
[31]. Initial work to characterize the biosynthesis pathways for penicillin and related 
compounds was stymied by difficulties with genetically analyzing the fungi and purifying 
the relevant enzymes [18]. However, with the great advances in molecular biology these 
pathways are very well characterized and have become the target of metabolic engineering 
techniques to improve the production of beta lactam antibiotics [116]. The biosynthesis 
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of penicillin is typically viewed as beginning with a reaction, catalyzed by ACV synthase, 
which condenses three amino acids, L-valine, L-cysteine and L-2-aminoadipate to form 
5-(L-a-aminoadipyl)-L-cysteinyl-D-valine (ACV) [18]. ACV then becomes isopenicillin N 
which can subsequently made into a number of compounds in the penicillin family. 
The ability of BPAT-S and BPAT-M to find the penicillin pathway was tested by using 
G6P as the start compound and penicillin as the target compound. The "penicillin" compound 
in KEGG (ID: C00395) is a generic compound that contains the chemical structure for the 
beta-lactam ring and the five-membered thiazolidine ring, characteristic of all penicillins. 
A "R" is used to represent the other chemical structures that can be attached to create 
different penicillin variants. BPAT-S and BPAT-M were given as input to conserve at least 
three carbons and the resulting top ranked pathways are depicted in Figures 5.19 and 5.20, 
respectively. BPAT-S used 71845 linear pathways ranging in length of 9 to 15 reactions. 
BPAT-M identified three different target atom markings, resulting in two different mutually 
exclusive combinations. 
In both of the results from BPAT-S and BPAT-M, the general branching scheme through 
L-valine and L-cysteine are found. The pathway through L-2-aminoadipate is not found 
because the carbons from L-2-aminoadipate are removed in the reaction between isopenicillin 
N and penicillin. This pathway is identified in the next example of cephalosporin C which 
proceeds through a similar pathway but retains the carbons of L-2-aminoadipate. The 
pathways to valine and cysteine from G6P are correct starting with pyruvate, but go through 
the shortcuts from G6P to pyruvate instead of more likely proceeding through glycolysis. 
As discussed with previous results, this is a common issue that computational methods for 
finding metabolic pathways face. 
The BPAT-S pathway, similary to the streptomycin result, presents a more complete 
picture of the biosynthesis of penicillin than the pathway found by BPAT-M. Since the 
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seed pathway used proceeds through valine, BPAT-S is able to correctly identify that valine 
is produced by using two molecules of pyruvate. Notably, this pathway is 12 reactions 
long and is in the middle of the tens of thousands of linear pathways used by BPAT-S. Yet, 
because BPAT-S is able to analyze a large number of these pathways efficiently this result is 
pulled to the top of the branched pathways. Additionally, BPAT-S finds the pathway through 
acyl-CoA that contributes one carbon to penicillin along with the "R" that represents the 
different side chains that can be attached to penicillin. Although the pathway from G6P 
to acyl-CoA is unusual, and likely toxic due to proceeding through hydrogen cyanide, it is 
found because of the generic nature of the acyl-CoA compound. Pathway searches for more 
specific varieties of penicillin may have better results. BPAT-M does not identify the second 
pathway through valine or through acyl-CoA because they both conserve less than three 
carbons and are therefore not contained in the linear pathways. 
5.5.9 a-D-Glucose 6-Phosphate to Cephalosporin C 
Cephalosporin C is also a beta lactam antibiotic that is synthesized by certain bacteria and 
fungi. Cephalosporin C is a broader spectum antibiotic than penicillin, but is not used 
clinicially because of its low potency [28]. However, it is an important precursor for a 
number of related antibiotics and has also been a target for increased production using 
metabolic engineering approaches [116]. The biosynthetic pathway for cephalosporin C is 
similar to penicillin as it begins with the the synthesis of ACV from L-valine, L-cysteine 
and L-2-aminoadipate [18]. The pathway then proceeds through isopenicillin N which then 
undergoes a series of reactions resulting in cephalosporin C. 
BPAT-S and BPAT-M were given as input G6P as the start compound, cephalosporin C 
as the target compound and three as the minimal number of carbons to conserve. BPAT-S 
used 31280 linear pathways of length ranging from 10 to 16 reactions. BPAT-M found 5 
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different target atom markings resulting in 18 different mutually exclusive combinations. 
The top ranked pathways for BPAT-S and BPAT-M are depicted in Figures 5.21 and 5.22, 
respectively. The top ranking pathways from BPAT-S and BPAT-M capture all three of the 
pathways to the reaction utilizing L-valine, L-cysteine and L-2-aminoadipate. 
The introduction of the L-2-aminoadipate pathway causes some interesting changes 
in the BPAT-S results as compared to the penicillin results. Since the pathway through 
glycerone phophate and L-2-aminoadipate is used as a seed pathway, BPAT-S can no longer 
identify the branched pathway from two molecules of pyruvate that creates valine. Instead, 
it tries to conserve all of the carbons through valine and finds a long and unlikely pathway 
instead. This is a tradeoff because L-2-aminoadipate is also created via a branched pathway 
and therefore using a pathway through valine results in a long and unlikely pathway for 
L-2-aminoadipate. In this case, the seed pathway through L-2-aminoadipate resulted in a 
smaller overall branched pathway. BPAT-S also identifies the branch through acetyl-CoA 
which contributes its acetyl group to deacetylcephalosporin C to make cephalosporin C. 
BPAT-M does not identify this branch because it only contributes two carbons, but obtains 
better pathways for the other parts of the pathway. 
Since the shorter pathways through valine and L-2-aminoadipate were both contained in 
the linear pathway set, BPAT-M is able to merge them together and obtain a more realistic 
pathway for cephalosporin C. The pathway correctly matches the known pathway from 
pyruvate and 2-oxoadipate on down. As with many of the results, the pathways from G6P to 
those compounds take some unusual shortcuts, in the pyruvate case it would be more likely 
to be made by glycolysis. It is interesting to note that BPAT-M is able to reveal more variety 
between the compounds as compared to BPAT-S, which will use the same branch between 
two different compounds. 
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Figure 5.21 : Top ranked pathway returned by BPAT-S for G6P to cephalosporin C, with the 
linear pathways conserving 3 carbons. 
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Figure 5.22 : Top ranked pathway returned by BPAT-M for G6P to cephalosporin C, with 
the linear pathways conserving 3 carbons. 
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5.5.10 a-D-Glucose 6-Phosphate to Erythromycin 
Erythromycin is a highly successful, broad-spectrum, macrolide antibiotic discovered in 
the early 1950s and quickly became the preferred drug for a wide variety of infections 
[124, 125]. Erythromycin is produced by bacteria Saccharopolyspora erythraea and is 
difficult to synthesize in the laboratory [87]. Therefore, several metabolic engineering 
approaches have been taken to improve the production of erythromycin and erythromycin 
precursors, both by modifying S. erythraea or inserting the genes required into other 
microorganisms such as E. coli [85, 89, 24, 99]. The biosynthesis of erythromycin has been 
well studied and proceeds in two major steps. The first is the construction of the macrocyclic 
lactone intermediate, 6-Deoxyerythronolide B (6DB) by 6DB synthase from six molecules 
of methylmalonyl-CoA and one propanoyl-CoA [59]. 6DB then undergoes a series of 
modifications that includes the attachment of two sugars, L-mycarose and D-desosamine, in 
order to produce erythromycin [127, 114]. 
Both BPAT-S and BPAT-M are able to find the relatively complex branched pathway for 
the biosynthesis of erythromycin using G6P as the start compound and conserving three 
carbons. BPAT-S was initialized with eight molecules of G6P and due to the large number 
of branches, k was limited to 200000, resulting in 2902 linear pathways ranging in length 
from 10 to 17 reactions. The default limits were retained for BPAT-M, which found 15 
different target atom markings, resulting in 4592 mutually exclusive combinations. The top 
ranking result for BPAT-S is found in Figure 5.23, with the seed pathway going through 
(S)-lactate. Overall, the pathway found by BPAT-S is similar to the top ranking result for 
BPAT-M, depicted in Figure 5.24. Both results find the proper pathway from pyruvate 
to the synthesis of 6DB and the addition of the two sugars to complete the synthesis of 
erythromycin. The branched pathways contain the known pathway for the D-desosamine 
and a pathway highly similar to the known pathway for the L-mycarose, except for a slight 
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Figure 5.23 : Top ranked pathway returned by BPAT-S for G6P to erythromycin, with the 
linear pathways conserving 3 carbons. 
shortcut through dTDP-4-dehydro-6-deoxy-L-mannose. 
The differences between the two reinforce a number of general trends that appear when 
comparing the results of BPAT-S and BPAT-M in previous results. BPAT-S is able to find a 
branch that conserves less carbons than the initial seed pathway, the one through S-adenosyl-
L-methionine, which does not appear in the BPAT-M results because it is not included in 
the original set of linear pathways. BPAT-M reveals more variety in the pathways between 
G6P to pyruvate, although the likely pathway through glycolysis is not found due to its 
length. There is a pathway from G6P to (S)-lactate in the BPAT-S pathway that is not in 
the BPAT-M pathway. BPAT-S is able to find that one molecule of G6P is able to result in 
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Figure 5.24 : Top ranked pathway returned by BPAT-M for G6P to erythromycin, with the 
linear pathways conserving 3 carbons. 
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one molecule of (5')-lactate and S-adenosyl-L-methionine. Although, due to their search 
methods, neither algorithm is able to identify that each molecule of G6P can result in two 
molecules of pyruvate. This occurs in BPAT-S because branches are not allowed to branch 
and in BPAT-M because pathways only merge at one point. This may be corrected in future 
work through either adding a post processing step or improving the algorithms to find these 
occurrences, which is further discussed in Section 6.1.1. 
5.5.11 a-D-Glucose 6-Phosphate to Lycopene 
Lycopene is a C40 carotenoid having a bright red color and is typically found in fruits and 
vegetables, such as tomatoes and watermelons. Popular interest in lycopene has grown 
because it is an antioxidant and studies indicate it may be helpful in the prevention and 
treatment of diseases such as cancer [97]. Lycopene's nutritional and pharmaceutial potential 
has resulted in a number of investigations on using metabolic engineering techniques to 
increase yield and/or produce lycopene in microbial hosts [101, 4, 132, 123], The biosyn-
thesis pathway of lycopene is relatively well understood and it utilizes several molecules of 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) [100], As discussed 
in result for (-)-carvone, IPP and DMAPP can be produced by either the mevalonate (MVA) 
pathway or the mefhylerythritol phosphate (MEP) pathway, depending on the organism. 
Lycopene proves to be an interesting test case for the branched pathfinding algorithms 
because it is a case where BPAT-M performs better than BPAT-S, likely due to the underlying 
structure of the lycopene biosynthesis pathway. BPAT-S and BPAT-M are given as the start 
compound G6P, the target compound lycopene and three as the number of carbons to 
conserve. Several of the default parameters to be readjusted because of the large number of 
carbons in lycopene and the complexity of the overall pathway. For BPAT-S, k was reduced 
to 500,000 because it would reach the maximum time allowed of 24 hours at the default 
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value. For BPAT-M, the number of pathways in each cluster was limited to 2,500 and r was 
set to 500 because it would run out of memory using the default values. BPAT-S analyzed 
22,064 linear pathways of length ranging from 14 to 21 reactions and BPAT-M found 16 
mutually exclusive target atom markings that generated 6,301 combinations. The top ranked 
results for BPAT-S and BPAT-M can be found in Figures 5.25 and 5.26, respectively. 
BPAT-M correctly finds the lycopene pathway that utilizes the MEP pathway to synthe-
size IPP and DMAPP. This pathway has an interesting topology as IPP and DMAPP are 
produced using the same reactions and then the GMAPP combines with IPP to make two 
molecules of geranyl diphosphate which are combined with IPP in two more sequential 
reactions resulting in two molecules of geranylgeranyl diphosphate, which combine to make 
the C40 molecule prephytoene diphosphate that becomes lycopene. This pathway topology 
lends itself well to discovery by BPAT-M because it is naturally a merging of several linear 
pathway of similar length that result in a complex branched pathway. 
BPAT-S has greater difficulty identifying the overall pathway, mainly because branches 
off of the seed pathway cannot further branch and this is required to generate the topology 
found by BPAT-M. Still, quite a bit of the general topology is contained in the top ranked 
pathway. Additionally, the result from BPAT-S does utilize both the MEP pathway for 
DMAPP and MVA pathway for IPP, thus revealing the variety available. However, similar 
to the (-)-carvone result, the pathway found from G6P to acetoacetyl-CoA to begin the MVA 
pathway is long and unwieldy because the branch is trying to conserve the maximum number 
of carbons without being able to branch. Lastly, the top ranked BPAT-S pathway contains 
cis forms of the intermediate compounds between prephyonene diphosphate and lycopene. 
These are valid reactions and compounds contained in the KEGG databases, and there is 
some evidence that they perhaps could occur, but they do not appear to be well characterized 
[43, 75]. The third ranked BPAT-S pathway contains the more well characterized trans forms 
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Figure 5.25 : Top ranked pathway returned by BPAT-S for G6P to lycopene, with the linear 
pathways conserving 2 carbons. 
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of the compounds from prephyonene diphosphate to lycopene and it is promising that the 
algorithm is capable of finding both pathways. 
5.5.12 Wall Time for Finding Branched Pathway 
The wall time taken on the system described in Section 5.3 to find the branched pathways 
by BPAT-S or BPAT-M is plotted in Figures 5.27 and 5.28, respectively. The maximum 
time allowed for a pathway search was 24 hours. The overall height of each bar indicates 
the total time and then the bars are partitioned into sections representing the times required 
for different stages of the algorithms. The plots reveal that for all pathways, except the 
one to (S)-norcoclaurine, BPAT-S took signficantly more time than BPAT-M. In the case of 
(S)-norcoclaurine, it took about a minute with BPAT-S and 14 seconds with BPAT-M. The 
wide variation of run times indicates that the time required is dependent on the start and 
target compound and is difficult to predict beforehand. 
Without any limits on the number of atoms conserved by the branches or the number 
of branches per seed pathways, BPAT-S typically takes on the order of hours to run. The 
run time of BPAT-S does not appear to be dependent on the complexity of the expected 
result, as the L-threonine pathway is a relatively simple branched pathway that took a long 
time to compute. There is also no clear trend in the relatively amount of times spent finding 
branches versus trying different combinations of branches. In several cases, finding branches 
appear to dominate the computation time. This happens in the L-threonine pathway as well 
and it seems to be because there are a large number of one carbon branches, if one limits the 
branches to conserve at least two carbons the run time falls dramatically to about 25 minutes. 
Other pathways,such as erythromycin and lycopene, are dominated by the time it takes to 
try combinations of branches. This is to be expected because these pathways require a large 
number of branches to synthesize their final target compounds. 
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Figure 5.27 : Wall times for BPAT-S for each branched pathway as indicated by the target 
compound labels. The dark teal is the time required for using LPAT to find the branches. 
The light green is the time required to try all combination of branches. The time required 
for finding the original set of linear pathways is so relatively negligible that it is not visible. 
131 
Figure 5.28 : Wall times for BPAT-M for each branched pathway as indicated by the target 
compound labels. The red is the time used by LPAT to find the set of linear pathways. The 
dark teal is the time used to construct M and the light green is the time used to merge the 
pathways using Q and C and M. The time required to construct Q and C is so relatively 
negligible that it is not visible. 
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The wall times for BPAT-M are significantly shorter for the same branched pathways 
than BPAT-S. However, this is likely because BPAT-M utilizes stricter cutoffs through the 
number of pathways kept for each TAM in Q and w. When these cutoffs were raised, the 
search would run out of memory before running out of time. Therefore, it is interesting 
that, at least by analyzing the top returned pathway, BPAT-M was able to perform as well as 
BPAT-S for many pathways. Since the times are so much shorter the time required to find 
the original linear pathways by LPAT is relatively more significant and shows up on the plot 
as the bottom, red section of the bars. For all of the pathways, the time to do the pairwise 
mergable comparisons of pathways to construct M took a few minutes or less. In the case of 
lycopene, and to a lesser extent stachyose, which took greater amounts of time to compute, 
the time required to merge the pathways dominated the computation. It is of note that the 
the lycopene pathway took the longest to compute and was the only one where BPAT-M 
was able to outperform BPAT-S. 
5.5.13 General Summary of Branched Pathway Results 
BPAT-S and BPAT-M take two different heuristic approaches for finding metabolic pathways 
and the experimental results reveal that their performance depends on the underlying struc-
ture of the pathway they seek to find. The approach taken by BPAT-S will perform better if 
there is one main linear pathway that transfers a significant portion of the mass from the 
start to target compound and the branches are smaller modifications. This occurs in the case 
of the tryptophan pathway, where four carbons are conserved through the shikimate pathway 
and the other carbons are lost and gained in shorter, two or three carbon branches. In other 
cases, BPAT-S is able to identify branches that conserve less carbons than the original linear 
pathways, something that BPAT-M is unable to do. However, the merging approach used 
by BPAT-M will perform better if all of the branches conserve at least the given number 
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of atoms and are of similar length. If this is the case, then BPAT-M can also find more 
complex topologies, because it is not limited to requiring all branches to start and end from 
the same pathway. This is typical of large compounds made from similar components, 
and the lycopene result highlights this ability of BPAT-M. The lycopene pathway utilizes 
a complex "interwoven" pattern that BPAT-S is unable to find, but is returned as the top 
result by BPAT-M. While it can be difficult to identify a priori which method will perform 
better, it is reasonable to try both approaches and analyze the results. By utilizing both 
approaches, researchers may gain insight into different metabolic schemes. Additionally, 
since the algorithms are complementary, future work may improve the performance by 
combining them as discussed in Section 6.1.1. 
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Chapter 6 
Conclusions and Future Directions 
The metabolic path finding algorithms presented in this thesis are part of a growing set 
of analysis tools that will assist in understanding metabolic networks and designing novel 
metabolic pathways for applications such as metabolic engineering and synthetic biology. 
Chapter 3 described a new algorithm, LPAT, that guarantees finding linear metabolic path-
ways between a start and target compound that conserve a given number of atoms. Chapter 
4 presented BPAT-S and BPAT-M, two new algorithms for heuristically finding branched 
metabolic pathways between a start and target compound. The experimental results in 
Chapter 5 demonstrated that while the theoretical complexity of finding even linear atom 
conserving pathways is high that the algorithms in this thesis have reasonable running 
times in practice. This is due to several factors including the appropriate representations 
and heuristics and the structure of the underlying metabolic network. The experimental 
results also provide inspiration for a number of future directions for improving metabolic 
pathfinding and the analysis of the resulting pathways. 
6.1 Future Directions 
The work presented in this thesis provides a solid foundation for future work on metabolic 
pathfinding. There are a number of interesting future directions to persue, some related to 
algorithmic improvements and other focusing on the analysis and visualization of the found 
pathways. 
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6.1.1 Improvements to BPAT-S and BPAT-M 
One of the clearest algorithmic extensions to the current work is to combine the complemen-
tary approaches taken by BPAT-S and BPAT-M. Currently, BPAT-S attaches branches to a 
single seed pathway generated from a single linear pathway returned by LPAT. However, 
it may improve results to generate "seed pathways" from the branched pathway results 
of BPAT-M. The combined method would proceed by processing each branched pathway 
returned by BPAT-M in the same manner as the linear pathways from LPAT by BPAT-S to 
identify places where atoms can be lost and gained. Then BPAT-S would go through the 
same method to attach new branches to the branched pathway from BPAT-M. In this way, 
the combined method takes advantage of the BPAT-M's ability to identify more complex 
topologies with BPAT-S's ability to identify branches that do not exist in the original set of 
linear pathways. Since the experimental results reveal that the time needed by BPAT-M is 
relatively small to the amount of time required by BPAT-S, combining the methods in this 
manner should not greatly increase the overall time required. 
Still, a combined method may not find certain topologies of branched pathways because 
the more complex topologies found by BPAT-M rely on the pathways being in the set of 
original linear pathways. An important question to ask is how common complex topologies 
are in biochemical systems and how useful are they for producing compounds of interest. 
As discussed in Chapter 2, there have been a number of studies on the average or overall 
topologies of metabolic networks, but there has not been as much work understanding the 
networks required to synthesize, or breakdown, one compound. A better understanding 
of the topologies that algorithms like BPAT-S and BPAT-M should be able to find can 
be used to guide the design of future extensions. If it turns out there are topologies that 
BPAT-M combined with BPAT-S cannot handle, another direction to explore would be 
to extend BPAT-S to allow branching from the branches, but how to proceed while still 
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having reasonable search times is less clear. One way to reduce the wall time required is to 
parallelize the algorithm, and in some sense it is embarrassingly parallel as each processor 
can be assigned a set of seed pathways. However, storing previously identified branches is 
important to the efficiency of BPAT-S, and so the algorithm may be better suited to shared 
memory systems, which are becoming more common with the rise of multi-core processors. 
6.1.2 Incorporating Known Biochemical Information 
A theme found in a number of the experimental results is that the computed pathways contain 
unusual shortcuts around glycolysis. This is because pathways are ranked by the number 
of reactions they use and glycolysis is a relatively long pathway. However, glycolysis is a 
highly conserved and universal metabolic pathway that generates energy and therefore, while 
perhaps interesting, the unusual shortcuts are unlikely to be used in reality. In some way, 
not identifying glycolysis could be perceived as a failing of the computational methods, but 
the end goal of these methods is to discover new and interesting pathways, not to rediscover 
well known pathways. At the same time, when finding branched pathways, better overall 
pathways may be found if well known pathways such as glycolysis are treated differently. 
One way to incorporate known metabolic pathways is to postprocess the resulting 
pathways. If the resulting pathways contain a different pathway between two compounds 
that are connected in a known pathway, then the known pathway can replace the found 
pathway. This may make the size of the overall pathway larger and experimentation would 
need to be done to understand how to count the size of the known pathway in the final 
ranking of the results. Another approach would be to incoporate the known metabolic 
pathways in the search itself. How to exactly do this raises a number of questions and would 
likely result in a redesign of the algorithms. For example, one way would be to search from 
both the start compound and target compound at the same time. If the search from the start 
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compound and the search from the target compound arrive at compounds that are connected 
by a known pathway then the searches can stop and the known pathway can just be used 
to connect the two pathways. In the end, the decision to incorporate known pathways will 
likely depend on the specific application. While the known pathways may make the results 
look better in terms of validation and testing, it is a balancing act between returning what is 
already known versus finding new or unusual pathways. 
6.1.3 Clustering and Analysis of Returned Pathways 
The experimental results in this thesis provide an initial cluster analysis of linear pathways 
that reveals that it may be of interest to consider the resulting pathways as a whole, instead 
of just manually analyzing the top ranked pathways. The analysis presented used a rela-
tively simple distance measure and agglomerative clustering method. Future work should 
investigate how the choice of measure and method change the results. For example, the 
distance measure used currently considers each compound as a completely independent 
entity, but this is not true because there is a notion of chemical similarity. Therefore, it is 
possible that incorporating chemical similarity when comparing two pathways may return 
more chemically relevant clusterings. Another important extension to understand how to 
cluster branched pathways. The main challenge is the development of a proper distance 
measure. Should the emphasis be placed on topological or chemical similarity, both, or 
something else entirely? Once the distance measure is developed, then based on the linear 
pathway results, it is likely that standard clustering methods will produce interesting results 
and hopefully further understanding of different metabolic schemes. 
138 
6.1.4 Visualization and Interactivity 
In the end, it is highly unlikely that any algorithm or ranking scheme will be able to return 
a perfect list of metabolic pathways for any application. This means, along with the large 
number of pathways typically returned, that it is important to develop good visualization 
tools that will allow researchers to interact with the results in a meaningful way. Some 
initial work has been done in implementing a webserver for these algorithms and enabling 
users to filter the pathways based on their compounds and reactions. However, providing 
interactive and useful visualizations of large numbers of metabolic pathways, especially 
branched pathways, pose a number of unique challenges that deserve future investigation. 
The goal of finding "biologically meaningful" and "realistic" metabolic pathways is not 
well-defined and while much effort has been put into validating and testing the algorithms in 
this thesis, the true test will be experimental validation of new and interesting computational 
results. 
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Table A.2 : Pathways in the Amino Acid Test Set 
Start Compound Target Compound Number of Number of 
Pathways Reactions 
in Longest 
Pathway 
PRPP 
Pyruvate 
Homocitrate 
L-Aspartate 
Pyruvate 
L-Glutamate 
L-Glutamate 
Propanoate 
L-Aspartate 
L-Threonine 
Pyruvate 
Chorismate 
L-Arginine 
L-Glutamine 
L-Aspartate 
L-Glutamate 
C02 
Chorismate 
Chorismate 
3-Phospho-D-glycerate 
L-Ornithine 
Cysteine 
Continued on Next Page 
L-Histidine 
L-Leucine 
L-Lysine 
L-Lysine 
L-Isoleucine 
L-Isoleucine 
L-Arginine 
L-isoleucine 
L-Methionine 
L-Isoleucine 
L-Valine 
L-Tryptophan 
L-Proline 
L-Arginine 
L-Threonine 
L-Proline 
L-Arginine 
L-Tyrosine 
L-Phenylalanine 
L-Serine 
L-Proline 
L-Asparagine 
2 
5 
2 
4 
1 
1 
2 
1 
3 
1 
2 
2 
2 
1 
1 
2 
1 
2 
2 
1 
3 
1 
10 
10 
9 
9 
9 
8 
8 
7 
7 
6 
6 
5 
5 
4 
4 
4 
4 
3 
3 
3 
3 
2 
Table A.2 - Continued 
Start Compound Target Compound Number of Number of 
Pathways Reactions 
in Longest 
Pathway 
Cysteine 
L-Threonine 
L-Serine 
Pyruvate 
L-Asparagine 
L-Cysteine 
L-Phenylalanine 
L-Serine 
L-Aspartate 
L-Aspartate 
Glyoxylate 
Oxaloacetate 
2-Oxoglutarate 
L-Glutamate 
Pyruvate 
C02 
L-Aspartate 
L-Glycine 
L-Cysteine 
L-Alanine 
L-Aspartate 
L-Alanine 
L-Tyrosine 
L-Glycine 
L-Asparagine 
L-Alanine 
L-Glycine 
L-Aspartate 
L-Glutamate 
L-Glutamine 
L-Serine 
L-Glycine 
1 
2 
2 
4 
1 
1 
1 
1 
2 
1 
3 
1 
4 
5 
1 
1 
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